<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Efficacy of psychostimulant drugs for amphetamine abuse or dependence - Pérez‐Mañá, C - 2013 | Cochrane Library</title> <meta content="Efficacy of psychostimulant drugs for amphetamine abuse or dependence - Pérez‐Mañá, C - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009695.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Efficacy of psychostimulant drugs for amphetamine abuse or dependence - Pérez‐Mañá, C - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009695.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009695.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Efficacy of psychostimulant drugs for amphetamine abuse or dependence" name="citation_title"/> <meta content="Clara Pérez‐Mañá" name="citation_author"/> <meta content="Universitat Autònoma de Barcelona" name="citation_author_institution"/> <meta content="cperez@imim.es" name="citation_author_email"/> <meta content="Xavier Castells" name="citation_author"/> <meta content="Universitat de Girona" name="citation_author_institution"/> <meta content="Marta Torrens" name="citation_author"/> <meta content="Hospital del Mar Research Institute‐IMIM, Parc de Salut Mar" name="citation_author_institution"/> <meta content="Dolors Capellà" name="citation_author"/> <meta content="Faculty of Medicine, Universitat de Girona" name="citation_author_institution"/> <meta content="Magi Farre" name="citation_author"/> <meta content="Universitat Autònoma de Barcelona" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD009695.pub2" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/09/02" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009695.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009695.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009695.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Amphetamine‐Related Disorders [*drug therapy]; Benzhydryl Compounds [therapeutic use]; Bupropion [therapeutic use]; Central Nervous System Stimulants [adverse effects, *therapeutic use]; Dextroamphetamine [therapeutic use]; Methylphenidate [therapeutic use]; Modafinil; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009695.pub2&amp;doi=10.1002/14651858.CD009695.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="xcg9958b";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009695\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009695\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009695.pub2",title:"Efficacy of psychostimulant drugs for amphetamine abuse or dependence",firstPublishedDate:"Sep 2, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Drugs and Alcohol Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xcg9958b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009695.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009695.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009695.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009695.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009695.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009695.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009695.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009695.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009695.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009695.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4846 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009695.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-sec-0070"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-sec-0052"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-sec-0064"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/appendices#CD009695-sec-0075"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/table_n/CD009695StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/table_n/CD009695StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Efficacy of psychostimulant drugs for amphetamine abuse or dependence</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/information#CD009695-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Clara Pérez‐Mañá</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/information#CD009695-cr-0003">Xavier Castells</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/information#CD009695-cr-0004">Marta Torrens</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/information#CD009695-cr-0005">Dolors Capellà</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009695.pub2/information#CD009695-cr-0006">Magi Farre</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/information/en#CD009695-sec-0083">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 02 September 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009695.pub2">https://doi.org/10.1002/14651858.CD009695.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009695-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009695-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009695-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009695-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009695-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009695-abs-0001" lang="en"> <section id="CD009695-sec-0001"> <h3 class="title" id="CD009695-sec-0001">Background</h3> <p>Amphetamine dependence is a public health problem with medical, psychiatric, cognitive, legal and socioeconomic consequences. To date, no pharmacological treatment has been approved for this disorder, and psychotherapy remains the mainstay of treatment. In recent years, psychostimulants have been investigated as a possible replacement therapy. </p> </section> <section id="CD009695-sec-0002"> <h3 class="title" id="CD009695-sec-0002">Objectives</h3> <p>To evaluate the efficacy and safety of psychostimulant medications for amphetamine abuse or dependence. The influences of type of drug, type of dependence, comorbid disorders, clinical trial risk of bias and publication of data were also studied. </p> </section> <section id="CD009695-sec-0003"> <h3 class="title" id="CD009695-sec-0003">Search methods</h3> <p>Relevant trials were searched in the following sources: PubMed (January 1966 to 6 June 2012), EMBASE (January 1988 to 6 June 2012), CENTRAL (<i>The Cochrane Library,</i> Issue 5 of 12, May 2012), PsycINFO (January 1985 to 6 June 2012) and the Specialised Register of the Cochrane Drug and Alcohol Group (June 2012). We also searched the reference lists of retrieved trials, the list of studies citing the included trials and the main electronic registers of ongoing trials (ClinicalTrials.gov, International Clinical Trials Registry Platform and EU Clinical Trials Register). Finally, we contacted investigators to request information about unpublished trials. Searches included non－English language literature. </p> </section> <section id="CD009695-sec-0004"> <h3 class="title" id="CD009695-sec-0004">Selection criteria</h3> <p>All randomised, placebo‐controlled, parallel‐group clinical trials investigating the efficacy or safety of psychostimulants for amphetamine dependence or abuse conducted in an outpatient setting. </p> </section> <section id="CD009695-sec-0005"> <h3 class="title" id="CD009695-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by The Cochrane Collaboration.</p> </section> <section id="CD009695-sec-0006"> <h3 class="title" id="CD009695-sec-0006">Main results</h3> <p>Eleven studies were included in the review (791 participants). Studied psychostimulants included dexamphetamine, bupropion, methylphenidate and modafinil. No significant differences were found between psychostimulants and placebo for any of the studied efficacy outcomes. Overall retention in studies was low (50.4%). Psychostimulants did not reduce amphetamine use (mean difference (MD) ‐0.26, 95% confidence interval (CI) ‐0.85 to 0.33) or amphetamine craving (MD 0.07, 95% CI ‐0.44 to 0.59) and did not increase sustained abstinence (relative risk (RR) 1.12, 95% CI 0.84 to 1.49). The proportion of adverse events inducing dropout was similar for psychostimulants and placebo (risk difference (RD) 0.01, 95% CI ‐0.03 to 0.04). The main findings did not change in any subgroup analysis. </p> </section> <section id="CD009695-sec-0007"> <h3 class="title" id="CD009695-sec-0007">Authors' conclusions</h3> <p>Results of this review do not support the use of psychostimulant medications at the tested doses as a replacement therapy for amphetamine abuse or dependence. Future research could change this conclusion, as the numbers of included studies and participants are limited and information on relevant outcomes, such as efficacy according to the severity of dependence or craving, is still missing. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009695-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009695-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009695-abs-0006">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009695-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009695-abs-0005">Français</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009695-abs-0004" lang="en"> <h3>Efficacy of psychostimulant drugs for amphetamine abuse or dependence</h3> <p>Amphetamine dependence constitutes a public health problem with many consequences and complications. Amphetamine abuse refers to a maladaptive and hazardous pattern of use considered to be less severe than dependence. To date, no pharmacological treatment has been approved for amphetamine abuse or dependence, and psychotherapy remains the best treatment option. </p> <p>Long‐term amphetamine use reduces dopamine levels in the brain. Drugs increasing dopamine and mimicking the effects of amphetamines with lower abuse liability could be used as replacement therapy in amphetamine dependence. Several psychostimulants have been studied recently for this purpose. </p> <p>In this review, the efficacy and safety of psychostimulants for amphetamine abuse or dependence were studied. We found eleven studies enrolling 791 amphetamine‐dependent participants and assessing the effects of four different psychostimulants: dexamphetamine, bupropion, methylphenidate and modafinil. Psychosocial interventions were additionally provided to all participants. The studies were conducted in the USA, Australia or Northern Europe, and study length ranged from 8 to 20 weeks. </p> <p>Psychostimulants did not reduce amphetamine use or amphetamine craving and also did not increase sustained abstinence in comparison with placebo. Retention in treatment was similar and low with both treatments. Psychostimulants also did not increase the risk of adverse events that were intense enough to induce dropouts. </p> <p>Research with larger and longer trials is needed to determine whether psychostimulants can be a useful replacement therapy for patients with amphetamine abuse or dependence. The design of future trials should consider the level of dependence at study entry, the potency and the dose of the psychostimulant administered, the length of the trial and the representativeness of included participants. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009695-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009695-sec-0070">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009695-sec-0112">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009695-sec-0070"></div> <h3 class="title" id="CD009695-sec-0071">Implications for practice</h3> <section id="CD009695-sec-0071"> <p>Overall, the results of this systematic review do not support the use of psychostimulants to treat amphetamine abuse or dependence. No drug at the tested doses has shown to be efficacious for the treatment of amphetamine dependence. </p> </section> <h3 class="title" id="CD009695-sec-0072">Implications for research</h3> <section id="CD009695-sec-0072"> <p>Future research should try to include outcomes more predictive of long‐term abstinence, such us "end of treatment abstinence" or "sustained abstinence" instead of "overall abstinence across the study" (<a href="./references#CD009695-bbs2-0017" title="McCannDJ , LiSH . A novel, non binary evaluation of success and failure reveals bupropion efficacy versus methamphetamine dependence: reanalysis of a multisite trial. CNS Neurosci Ther2012;18(5):414‐8. ">McCann 2012</a>). It should be mentioned that the outcome sustained abstinence was a preplanned endpoint in only one of the studies included in this review (<a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>). </p> <p>Subgroup analysis of two included studies with bupropion (<a href="./references#CD009695-bbs2-0003" title="ElkashefAM , RawsonRA , AndersonAL , LiSH , HolmesT , SmithEV , et al. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology2008;33(5):1162‐70. ">Elkashef 2008 a</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>) has shown favourable results in participants with light to moderate consumption of amphetamines before screening or at baseline. The degree of amphetamine consumption at the beginning of the trial (<a href="./references#CD009695-bbs2-0014" title="DeanAC , LondonED , SugarCA , KitchenCM , SwansonAN , HeinzerlingKG , et al. Predicting adherence to treatment for methamphetamine dependence from neuropsychological and drug use variables. Drug Alcohol Depend2009;105(1‐2):48‐55. ">Dean 2009</a>) and the achievement of early abstinence (<a href="./references#CD009695-bbs2-0032" title="BrensilverM , HeinzerlingKG , SwansonAN , ShoptawS . A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: suggested guidelines for treatment discontinuation/augmentation. Drug Alcohol Depend2012;125(1‐2):169‐72. ">Brensilver 2012</a>) are good predictors of future response. The potency of the psychostimulant drug is another important factor to consider. It seems reasonable to test stronger psychostimulants in severely addicted participants, while mild psychostimulants could be reserved for those with lower rates of consumption. It could also be argued that the doses of psychostimulants used in these trials are not high enough to replace the effects of the abused drug in this kind of population (<a href="./references#CD009695-bbs2-0050" title="HerinDV , RushCR , GrabowskiJ . Agonist‐like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Annals of the New York Academy of Sciences2010;1178:76‐100. ">Herin 2010</a>). </p> <p>It could be desirable to carry out studies with longer follow‐up, as it has been suggested that 12‐week clinical trials are not long enough to assess treatment efficacy in chronic conditions like addiction (<a href="./references#CD009695-bbs2-0020" title="WinchellC , RappaportBA , RocaR , RosebraughCJ . Reanalysis of methamphetamine dependence treatment trial. CNS Neurosci Ther2012;18(5):367‐8. ">Whinchell 2012</a>). These studies may also provide necessary data about long‐term safety. </p> <p>Finally, the efficacy of psychostimulants in methadone‐maintained dual heroin‐amphetamine－dependent patients should be investigated because psychostimulant maintenance has shown promising results in dual cocaine‐heroin－ dependent participants (<a href="./references#CD009695-bbs2-0034" title="CastellsX , CasasM , Pérez‐MañáC , RonceroC , VidalX , CapellàD . Efficacy of Psychostimulant Drugs for Cocaine Dependence. Cochrane Database of Systematic Reviews2010, Issue 2. [DOI: 10.1002/14651858.CD007380.pub3] ">Castells 2010</a>). To our knowledge, no study has yet investigated this intervention in dual heroin‐amphetamine－dependent participants. </p> <p>In summary, future research should consider carefully the level of dependence at study entry, the potency and dose of the psychostimulant administered, the length of the trial and the representativeness of included participants. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009695-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009695-sec-0022"></div> <div class="table" id="CD009695-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Psychostimulants for amphetamine abuse or dependence</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Psychostimulants for amphetamine abuse or dependence</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Amphetamine abuse or dependence<br/> <b>Settings:</b> Outpatients<br/> <b>Intervention:</b> Psychostimulants </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Psychostimulants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Amphetamine use (UA)</b> <br/> Negative urinalyses across the study<br/> Follow‐up: 8‐12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean of the proportion of amphetamine‐negative UA ranged in the control groups from 0.56 to 33.1 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean of the proportion of amphetamine‐negative UA ranged in the intervention groups from 0.33 to 36.85 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>473<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD ‐0.26</b> </p> <p>(‐0.85 to 0.33)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Sustained abstinence</b> <br/> Negative urinalyses for at least 3 consecutive weeks<br/> Follow‐up: mean 8‐12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.12</b> <br/> (0.84 to 1.49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>559<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>220 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>247 per 1000</b> <br/> (185 to 328) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>285 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>319 per 1000</b> <br/> (239 to 425) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Retention to treatment</b> <br/> Number of participants who competed treatment<br/> Follow‐up: 8‐20 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.01</b> <br/> (0.9 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>791<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3,4,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>489 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>494 per 1000</b> <br/> (440 to 557) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>378 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>382 per 1000</b> <br/> (340 to 431) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence:<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The outcome is not influenced by lack of blinding, but high attrition in trials has been noted.<br/> <sup>2</sup>No statistical heterogeneity was found.<br/> <sup>3</sup>The studied intervention includes different types of psychostimulants and different doses.<br/> <sup>4</sup>95% CI is wide, and the intervention effect over this outcome can range from no benefit to small effect.<br/> <sup>5</sup>Funnel plot not suggested publication bias. Statistical power is low in using tests to detect publication bias for this comparison in this review.<br/> <sup>6</sup>This comparison includes studies with treatment length ranging from 8 to 20 weeks. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009695-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009695-sec-0023">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009695-sec-0092">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD009695-sec-0023"></div> <section id="CD009695-sec-0024"> <h3 class="title" id="CD009695-sec-0024">Description of the condition</h3> <p>Globally, amphetamines rank as the second most used illicit drug after cannabis, followed by cocaine and opiates. Methamphetamine and amphetamine are the most widely consumed synthetic stimulants (<a href="./references#CD009695-bbs2-0078" title="Patterns and consequences of the use of amphetamine‐type stimulants. http://www.who.int/hiv/pub/idu/ats_brief1.pdf. A ccessed 1 July 20 1 1 . ">WHO Technical Briefs 2011</a>). The United Nations Office on Drugs and Crime estimated in 2010 a prevalence of 0.3 to 1.2 per cent, or between 14 million and 52.5 million global users of amphetamines (excluding ecstasy). On the other hand, the number of ecstasy‐group users is smaller and ranged in 2010 between 10.5 million and 28 million people worldwide (0.2% to 0.6% of all adults aged 15 to 64) (<a href="./references#CD009695-bbs2-0077" title="UNODC . World Drug Report 2012. United Nations Publication, Sales No. E.12.XI.12012. ">UNODC 2012</a>). </p> <p>Amphetamine dependence is a consequence of long‐term amphetamine use and is considered a major global health problem. Smoked or injected amphetamines more commonly lead to dependence than does the oral form. </p> <p>Amphetamine abuse refers to a maladaptive and hazardous pattern of use considered to be less severe than dependence. Amphetamine dependence occurs when an individual uses one or more of the amphetamine substances in a maladaptive way, resulting in at least three of the following symptoms: a need for increased quantities of amphetamines to achieve the desired subjective effect (tolerance); the presence of withdrawal symptoms such as depression, fatigue, insomnia or hypersomnia, increased appetite or agitation; use of amphetamines in larger amounts or for longer duration; a persistent, unsuccessful attempt to control use of the substance; increased amount of time spent using or obtaining amphetamines; giving up important activities in deference to the use of amphetamines; and continued amphetamine use despite related physical, emotional, occupational, legal or relational difficulties (<a href="./references#CD009695-bbs2-0041" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000. ">DSM IV TR</a>). </p> <p>Dopamine dysfunction has been postulated as the main neurobiological mechanism involved in amphetamine dependence. Although amphetamine use is associated with an increase in dopamine in the nucleus accumbens, in response to long‐term amphetamine use a hypo‐dopaminergic state has been observed (<a href="./references#CD009695-bbs2-0035" title="ChangL , AlicataD , ErnstT , VolkowN . Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction2007;102:16‐32. ">Chang 2007</a>; <a href="./references#CD009695-bbs2-0073" title="ShearerJ . The principles of agonist pharmacotherapy for psychostimulant dependence. Drug and Alcohol Reviews2008;27(3):301‐8. ">Shearer 2008</a>). Otherwise, cessation and appearance of withdrawal symptoms can be explained by functional dopamine hypoactivity in the striatum (<a href="./references#CD009695-bbs2-0058" title="KoobGF . Neurobiological substrates for the dark side of compulsivity in addiction. Neuropsychopharmacology2009;56(1):18‐31. ">Koob 2009</a>; <a href="./references#CD009695-bbs2-0070" title="RossettiZL , HmaidanY , GessaGL . Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. European Journal of Pharmacology1992;221:227‐34. ">Rossetti 1992</a>). </p> <p>The presence of other comorbidities in amphetamine‐dependent patients is not an exception. Amphetamine dependence is associated with depressive, anxiety and psychotic disorders (<a href="./references#CD009695-bbs2-0071" title="SaloR , FlowerK , KielsteinA , LeamonMH , NordahlTE , GallowayGP . Psychiatric comorbidity in methamphetamine dependence. Psychiatry Research2011;186(2‐3):356‐61. ">Salo 2011</a>), with attention deficit hyperactivity disorder (ADHD) (<a href="./references#CD009695-bbs2-0079" title="WilensTE . Attention‐deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk,and treatment issues. Psychiatric Clinics of North America2004;27(2):283‐301. ">Wilens 2004</a>) and with antisocial personality disorder (<a href="./references#CD009695-bbs2-0046" title="Glasner‐EdwardsS , MooneyLJ , Marinelli‐CaseyP , HillhouseM , AngA , RawsonRA , Methamphetamine Treatment Project Corporate Authors. Psychopathology in methamphetamine‐dependent adults 3 years after treatment. Drug and Alcohol Reviews2010;29:12‐20. ">Glasner‐Edwards 2010</a>). The high rate of comorbidities is expected to increase the difficulty of managing these patients (<a href="./references#CD009695-bbs2-0045" title="Glasner‐EdwardsS , Marinelli‐CaseyP , HillhouseM , AngA , MooneyLJ , RawsonR , Methamphetamine Treatment Project Corporate Authors. Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3‐year follow‐up. The Journal of Nervous and Mental Disease2009;197(4):225‐31. ">Glasner‐Edwards 2009</a>). In addition, amphetamine misuse has been associated with sexual risk behaviours and increased risk of human immunodeficiency virus (HIV) (<a href="./references#CD009695-bbs2-0037" title="ColfaxG , SantosGM , ChuP , VittinghoffE , PluddemannA , KumarS , et al. Amphetamine‐group substances and HIV. Lancet2010;376:458‐74. ">Colfax 2010</a>). </p> </section> <section id="CD009695-sec-0025"> <h3 class="title" id="CD009695-sec-0025">Description of the intervention</h3> <p>Amphetamine‐type stimulants (ATSs) are a group of drugs comprising synthetic stimulants such as the amphetamine‐group substances (like amphetamine and methamphetamine) and the ecstasy‐group substances (like 3,4‐methylenedioxymethamphetamine, also called MDMA). In this review, the word "amphetamines" stands for all them. </p> <p>Amphetamines increase synaptic dopamine (DA), norepinephrine (NE) and serotonin (5‐HT) concentrations by inhibiting the presynaptic membrane transporters (DAT, NET and SERT, respectively). Also they can reverse the action of the transporters facilitating neurotransmitter efflux into the synaptic cleft and can displace newly synthesised neurotransmitters from the vesicle stores. Finally, they inhibit monoamine oxidase, the enzyme responsible for the metabolism of the neurotransmitters (<a href="./references#CD009695-bbs2-0052" title="HowellLL , KimmelHL . Monoamine transporters and psychostimulant addiction. Biochemical Pharmacology2008;75(1):196‐217. ">Howell 2008</a>; <a href="./references#CD009695-bbs2-0069" title="RobinsonJB . Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors. Enantiomers of amphetamine, N‐methylamphetamine and deprenyl. Biochemical Pharmacology1985;34(23):4105‐8. ">Robinson 1985</a>; <a href="./references#CD009695-bbs2-0081" title="ZahniserNR , SorkinA . Trafficking of dopamine transporters in psychostimulant actions. Seminars in Cell &amp; Developmental Biology2009;20(4):411‐7. ">Zahniser 2009</a>). These drugs have in common that they excite the central nervous system (CNS) and speed up body functions. Amphetamines induce euphoria, increase alertness, decrease appetite and fatigue, increase heart rate, blood pressure and breathing rate, constrict blood vessels, dilate pupils and release glucose and lipids into the bloodstream. These substances can be taken orally, snorted, smoked or injected intravenously, and their effects may appear in 30 to 40 minutes and last for 4 to 8 hours. </p> <p>Methamphetamine is typically characterised as a more potent psychostimulant than non‐methylated amphetamine. At comparable doses, higher levels get into the brain because it is more lipophilic (<a href="./references#CD009695-bbs2-0067" title="Methamphetamine: Abuse and Addiction. NIDA Research Report2006; Vol. NIH Publication Number 06‐4210. ">NIDA 2006</a>). Nevertheless, published data support both drugs as having a similar profile of effects and equivalent abuse potential (<a href="./references#CD009695-bbs2-0056" title="KirkpatrickMG , GundersonEW , JohansonCE , LevinFR , FoltinRW , HartCL . Comparison of intranasal methamphetamine and d‐amphetamine self‐administration by humans. Addiction2012;107(4):783‐91. [DOI: 10.1111/j.1360‐0443.2011.03706.x] ">Kirkpatrick 2012 b</a>). Short‐ and long‐term effects of methamphetamine are similar to those produced by cocaine (another potent psychostimulant), but the effects of methamphetamine last longer and can be stronger (<a href="./references#CD009695-bbs2-0065" title="NewtonTF , De LaGarzaR , KalechsteinAD , NestorL . Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects. Pharmacology Biochemistry and Behaviour2005;82(1):90‐7. ">Newton 2005</a>). </p> <p>No typical profile of an amphetamine user is known, and amphetamines are used for different purposes. Amphetamines can be used by students or drivers to stay awake, by athletes to enhance performance and at parties or clubs (club drugs) to increase sociability (<a href="./references#CD009695-bbs2-0078" title="Patterns and consequences of the use of amphetamine‐type stimulants. http://www.who.int/hiv/pub/idu/ats_brief1.pdf. A ccessed 1 July 20 1 1 . ">WHO Technical Briefs 2011</a>). </p> <p>This review will be focused on the use of psychostimulant drugs as a substitution therapy for amphetamine abuse or dependence. By definition, medications used as maintenance therapy should have similar properties (mechanism of action, behavioural effects) to the abused drug, but with less addictive potential. The objective is to avoid illicit parenteral drug use by providing orally administered legal compounds. The rationale for use of psychostimulants to treat amphetamine dependence is based on previous successful results of replacement therapy for nicotine (<a href="./references#CD009695-bbs2-0043" title="EisenbergMJ , FilionKB , YavinD , BélisleP , MottilloS , JosephL , et al. Pharmacotherapies for smoking cessation: a meta‐analysis of randomised controlled trials. Canadian Medical Association Journal2008;179(2):135‐44. ">Eisenberg 2008</a>) or opiate dependence (<a href="./references#CD009695-bbs2-0028" title="AmatoL , DavoliM , PerucciCA , FerriM , FaggianoF , MattickRP . An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. The Journal of Substance Abuse Treatment2005;28(4):321‐9. ">Amato 2005</a>). </p> <p>To replace amphetamines for patients with amphetamine abuse or dependence, two different strategies should be considered: first, the use of milder psychostimulants with lower abuse potential, like caffeine, bupropion or modafinil; second, the use of sustained‐release formulations of classical psychostimulants like methylphenidate or dexamphetamine. Such formulations allow once‐ or twice‐daily dosing and therefore improve compliance (<a href="./references#CD009695-bbs2-0050" title="HerinDV , RushCR , GrabowskiJ . Agonist‐like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Annals of the New York Academy of Sciences2010;1178:76‐100. ">Herin 2010</a>). Immediate‐release formulations of potent psychostimulants, a priori, are a less desirable option because of their potential for abuse. </p> </section> <section id="CD009695-sec-0026"> <h3 class="title" id="CD009695-sec-0026">How the intervention might work</h3> <p>Psychostimulants may substitute the use of amphetamines by reducing amphetamine withdrawal (<a href="./references#CD009695-bbs2-0063" title="McGregorC , SrisurapanontM , MitchellA , WickesW , WhiteJM . Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual. The Journal of Substance Abuse Treatment2008;35(3):334‐42. ">McGregor 2008</a>) and craving (<a href="./references#CD009695-bbs2-0066" title="NewtonTF , RoacheJD , De laGarzaR2nd , FongT , WallaceCL , LiSH , et al. Bupropion reduces methamphetamine‐induced subjective effects and cue‐induced craving. Neuropsychopharmacology2006;31(7):1537‐44. ">Newton 2006</a>), thereby leading to abstinence. Additionally, the use of psychostimulant drugs simultaneously with amphetamines can reduce the euphoriant and reinforcing effects of amphetamines (<a href="./references#CD009695-bbs2-0038" title="De LaGarzaR2nd , ZorickT , LondonED , NewtonTF . Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine‐dependent volunteers. Drug and Alcohol Dependence2010;106(2‐3):173‐80. ">De la Garza 2010</a>), which also could promote reduction of amphetamine use. Finally, long‐term increases in DA in the nucleus accumbens achieved by other psychostimulants different from the abused drug could improve the established dopaminergic dysfunction in amphetamine‐dependent patients (<a href="./references#CD009695-bbs2-0080" title="XiZX , GardnerEL . Hypothesis‐driven medication discovery for the treatment of psychostimulant addiction. Current Drug Abuse Reviews2008;1(3):303‐27. ">Xi 2008</a>). </p> <p>Previous preclinical and human laboratory studies have shown promising results for psychostimulants (amphetamine substitution, attenuation of amphetamine reinforcing and subjective effects and reduction of amphetamine self‐administration). Those results encouraged the performance of several clinical studies with these drugs, most of them carried out in recent years. Several experts on the topic have suggested that doses of psychostimulants used to replace amphetamines in dependent patients should be higher than those used to treat other disorders such as ADHD, obesity or narcolepsy. A possible explanation for this fact could be that chronic stimulant abuse decreases sensitivity to those medications. Additionally, the severity of the dependence may explain the different utility of particular psychostimulants in specific subgroups of patients. Strong psychostimulants may be appropriate for severely dependent patients, while mild psychostimulants could be useful for patients with a less severe disorder (<a href="./references#CD009695-bbs2-0050" title="HerinDV , RushCR , GrabowskiJ . Agonist‐like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Annals of the New York Academy of Sciences2010;1178:76‐100. ">Herin 2010</a>). </p> </section> <section id="CD009695-sec-0027"> <h3 class="title" id="CD009695-sec-0027">Why it is important to do this review</h3> <p>To date, no pharmacological treatment has been approved for amphetamine abuse or dependence, although different kinds of drugs have been tested (<a href="./references#CD009695-bbs2-0036" title="ChenH , WuJ , ZhangJ , HashimotoK . Recent topics on pharmacotherapy for amphetamine‐type stimulants abuse and dependence. Current Drug Abuse Reviews2010;3(4):222‐38. ">Chen 2010</a>; <a href="./references#CD009695-bbs2-0053" title="KarilaL , WeinsteinA , AubinHJ , BenyaminaA , ReynaudM , BatkiSL . Pharmacological approaches to methamphetamine dependence: a focused review. Bristish Journal of Clinical Pharmacology2010;69(6):578‐92. ">Karila 2010</a>; <a href="./references#CD009695-bbs2-0076" title="SrisurapanontM , JarusuraisinN , KittirattanapaiboonP . Treatment for amphetamine dependence and abuse. Cochrane Database of Systematic Reviews2001, Issue 4. [DOI: 10.1002/14651858.CD003022] ">Srisurapanont 2001</a>). On the other hand, psychosocial interventions have shown modest results (<a href="./references#CD009695-bbs2-0057" title="KnappWP , SoaresBG , FarrelM , LimaMS . Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database of Systematic Reviews2007, Issue 3. [DOI: 10.1002/14651858.CD003023.pub2] ">Knapp 2007</a>; <a href="./references#CD009695-bbs2-0060" title="LeeNK , RawsonRA . A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug and Alcohol Reviews2008;27(3):309‐17. ">Lee 2008</a>; <a href="./references#CD009695-bbs2-0072" title="ShearerJ . Psychosocial approaches to psychostimulant dependence: a systematic review. The Journal of Substance Abuse Treatment2007;32(1):41‐52. ">Shearer 2007</a>), suggesting the need for a medication that could enhance their effectiveness. </p> <p>Two previous Cochrane reviews (<a href="./references#CD009695-bbs2-0074" title="ShoptawSJ , KaoU , HeinzerlingK , LingW . Treatment for amphetamine withdrawal. Cochrane Database of Systematic Reviews2009, Issue 2. [DOI: 10.1002/14651858.CD003021.pub2] ">Shoptaw 2009</a>; <a href="./references#CD009695-bbs2-0076" title="SrisurapanontM , JarusuraisinN , KittirattanapaiboonP . Treatment for amphetamine dependence and abuse. Cochrane Database of Systematic Reviews2001, Issue 4. [DOI: 10.1002/14651858.CD003022] ">Srisurapanont 2001</a>) have investigated participants with amphetamine‐related disorders－one including all different medications studied to that moment for amphetamine dependence (mainly antidepressants), and the other focused on treatment for amphetamine withdrawal symptoms, with both reviews highlighting the need for continued research in this area. </p> <p>Indirect dopamine agonists used to treat psychostimulant abuse or dependence showed promising results in a recent systematic review, but conclusions were based mainly on cocaine‐dependent participants because the evidence for amphetamine abuse or dependence was limited (<a href="./references#CD009695-bbs2-0068" title="Pérez‐MañáC , CastellsX , VidalX , CasasM , CapellàD . Efficacy of indirect dopamine agonists for psychostimulant dependence: a systematic review and meta‐analysis of randomized controlled trials. The Journal of Substance Abuse Treatment2011;40(2):109‐22. ">Pérez‐Mañá 2011</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009695-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009695-sec-0028">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009695-sec-0097">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009695-sec-0028"></div> <p>To evaluate the efficacy and safety of psychostimulant medications for amphetamine abuse or dependence. The influences of type of drug, type of dependence, comorbid disorders, clinical trial risk of bias and publication of data were also studied. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009695-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009695-sec-0029">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009695-sec-0098">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009695-sec-0029"></div> <section id="CD009695-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009695-sec-0031"> <h4 class="title">Types of studies</h4> <p>All randomised, placebo‐controlled, parallel‐group clinical trials investigating the efficacy or safety of psychostimulants for amphetamine dependence or abuse conducted in an outpatient setting. </p> </section> <section id="CD009695-sec-0032"> <h4 class="title">Types of participants</h4> <p>Participants with amphetamine abuse or dependence, according to the criteria of the <i>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision</i> (<a href="./references#CD009695-bbs2-0041" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association, 2000. ">DSM IV TR</a> or previous versions). Patients with additional comorbidities were also included (and were studied later in subgroup analyses). </p> </section> <section id="CD009695-sec-0033"> <h4 class="title">Types of interventions</h4> <p><b>Experimental intervention</b> </p> <p> <ul id="CD009695-list-0001"> <li> <p>Any psychostimulant medication alone or in combination with psychosocial interventions. Psychostimulants were any drugs with acute CNS stimulant effects defined as increased CNS activity resulting in fatigue relief, increased locomotor activity and anorexia in healthy participants (<a href="./references#CD009695-bbs2-0030" title="BoutrelB , KoobGF . What keeps us awake: the neuropharmacology of stimulants and wakefulness‐promoting medications. Sleep2004;27:1181‐94. ">Boutrel 2004</a>; <a href="./references#CD009695-bbs2-0054" title="KingGR , EllinwoodEH . Amphetamines and other stimulants. In: LowinsonJH , RuizP , MillmanRB , LangrodJG editor(s). Substance Abuse. A Comprehensive Textbook. 4th Edition. Philadelphia, PA: Lippincott Williams &amp; Wilkins, 2005:207‐22. ">King 2005</a>; <a href="./references#CD009695-bbs2-0059" title="KosmanME , UnnaDR . Effects of chronic administration of the amphetamines and other stimulants on behavior. Clinical Pharmacology &amp; Therapeutics1968;9:240‐54. ">Kosman 1968</a>). The criteria adopted to classify drugs as psychostimulants were the same as those used in two previous reviews on cocaine dependence. Drugs included had at least one published study showing psychostimulant effects (<a href="./references#CD009695-bbs2-0033" title="CastellsX , CasasM , VidalX , BoschR , RonceroC , Ramos‐QuirogaJA , et al. Efficacy of central nervous system stimulant treatment for cocaine dependence: a systematic review and meta‐analysis of randomized controlled clinical trials. Addiction2007;102(12):1871‐87. ">Castells 2007</a>; <a href="./references#CD009695-bbs2-0034" title="CastellsX , CasasM , Pérez‐MañáC , RonceroC , VidalX , CapellàD . Efficacy of Psychostimulant Drugs for Cocaine Dependence. Cochrane Database of Systematic Reviews2010, Issue 2. [DOI: 10.1002/14651858.CD007380.pub3] ">Castells 2010</a>). We did not limit the review to those drugs with CNS‐stimulating effects that directly target DA neurotransmission; at that time, xanthines were also included. The list of psychostimulants used for the search included classical (strong) psychostimulants, like amphetamine or methylphenidate, and mild psychostimulants, like bupropion, modafinil or caffeine. </p> </li> </ul> </p> <p>Amphetamine withdrawal may last for up to 4 weeks; therefore we decided to exclude studies that lasted less than 4 weeks. </p> <p><b>Control intervention</b> </p> <p> <ul id="CD009695-list-0002"> <li> <p>Placebo alone or in combination with psychosocial interventions.</p> </li> </ul> </p> </section> <section id="CD009695-sec-0034"> <h4 class="title">Types of outcome measures</h4> <section id="CD009695-sec-0035"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD009695-list-0003"> <li> <p>Efficacy primary outcomes.</p> </li> </ul> <ul class="plain" id="CD009695-list-0004"> <li> <ul id="CD009695-list-0005"> <li> <p>Amphetamine use (definition 1). Mean (standard deviation (SD)) negative urinalyses (UA) across the study. </p> </li> <li> <p>Amphetamine use (definition 2). Amphetamine concentration in hair analysis.</p> </li> <li> <p>Sustained amphetamine abstinence. Number of participants who achieved sustained amphetamine abstinence. </p> </li> </ul> </li> </ul> </p> </section> <section id="CD009695-sec-0036"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009695-list-0006"> <li> <p>Efficacy secondary outcomes.</p> </li> </ul> <ul class="plain" id="CD009695-list-0007"> <li> <ul id="CD009695-list-0008"> <li> <p>Self‐reported amphetamine use. The mean (SD) of days of amphetamine use across the study. </p> </li> <li> <p>Retention in treatment. Number of participants who completed the treatment.</p> </li> <li> <p>Amphetamine craving. Assessed by validated scales such as a visual analog scale (VAS) or the Brief Substance Craving Scale (BSCS) (<a href="./references#CD009695-bbs2-0040" title="DrobesDJ , ThomasSE . Assessing craving for alcohol. Alcohol Research &amp; Health1999;23:179‐86. ">Drobes 1999</a>; <a href="./references#CD009695-bbs2-0075" title="SomozaE , DyrenforthS , GoldsmithJ , MezinskisJ , CohenM . In search of a universal drug craving scale. Proceedings of the Annual Meeting of the American Psychiatric Association, Miami, Florida. 1995. ">Somoza 1995</a>). The mean (SD) craving score at study end. </p> </li> <li> <p>Depressive symptoms severity. Assessed by validated scales such as Hamilton Depression Rating Scale (HDRS or HAM‐D) (<a href="./references#CD009695-bbs2-0049" title="HamiltonM . A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry1960;23:56‐62. ">Hamilton 1960</a>). The mean (SD) depression score at study end. </p> </li> <li> <p>Anxiety symptoms severity. Assessed by validated scales such as Hamilton Anxiety Scale (HAM‐A) (<a href="./references#CD009695-bbs2-0048" title="HamiltonM . The assessment of anxiety states by rating. British Journal of Medical Psychology1959;32:50‐5. ">Hamilton 1959</a>). The mean (SD) anxiety score at study end. </p> </li> <li> <p>Overall functioning. Assessed by validated scales such as Clinical Global Impression (CGI) rating scales (<a href="./references#CD009695-bbs2-0047" title="GuyW . In: Clinical Global Impressions: ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute for Mental Health, 1976. ">Guy 1976</a>).The mean (SD) global impression scale score at study end. </p> </li> </ul> </li> </ul> <ul id="CD009695-list-0009"> <li> <p>Safety secondary outcomes.</p> </li> </ul> <ul class="plain" id="CD009695-list-0010"> <li> <ul id="CD009695-list-0011"> <li> <p>Number of participants who dropped out because of any adverse event (AE).</p> </li> <li> <p>Number of participants who dropped out because of cardiovascular adverse events.</p> </li> <li> <p>Number of participants who dropped out because of psychiatric adverse events.</p> </li> </ul> </li> </ul> </p> </section> </section> </section> <section id="CD009695-sec-0037"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009695-sec-0038"> <h4 class="title">Electronic searches</h4> <p>Relevant trials were obtained from the following sources.</p> <p> <ul id="CD009695-list-0012"> <li> <p>PubMed (January 1966 to 6 June 2012).</p> </li> <li> <p>EMBASE (January 1988 to 6 June 2012).</p> </li> <li> <p>CENTRAL (<i>The Cochrane Library,</i> Issue 5 of 12, May 2012). </p> </li> <li> <p>PsycINFO (January 1985 to 6 June 2012).</p> </li> <li> <p>Cochrane Drug and Alcohol Group Specialised Register (June 2012).</p> </li> </ul> </p> <p>Databases were searched using a strategy developed by incorporating the filter for identification of RCTs (<a href="./references#CD009695-bbs2-0051" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>) combined with selected MeSH terms and free text terms related to amphetamine dependence. The PubMed search strategy was used with the other databases by inserting appropriate controlled vocabulary as applicable. Access was always performed through Ovid SP. </p> <p>The search strategy used in the different databases is shown in <a href="./appendices#CD009695-sec-0076">Appendix 1</a>; <a href="./appendices#CD009695-sec-0077">Appendix 2</a>; <a href="./appendices#CD009695-sec-0078">Appendix 3</a>; <a href="./appendices#CD009695-sec-0079">Appendix 4</a>; and <a href="./appendices#CD009695-sec-0080">Appendix 5</a>. </p> <p>We searched for ongoing clinical trials and unpublished studies via Internet searches on the following Websites. </p> <p> <ul id="CD009695-list-0013"> <li> <p>http://apps.who.int/trialsearch/</p> </li> <li> <p>http://clinicaltrials.gov/</p> </li> <li> <p>https://www.clinicaltrialsregister.eu/</p> </li> </ul> </p> </section> <section id="CD009695-sec-0039"> <h4 class="title">Searching other resources</h4> <p> <ul id="CD009695-list-0014"> <li> <p>The reference lists of retrieved studies and relevant review articles were inspected to identify additional studies. </p> </li> <li> <p>For each included study, a citation search was performed in ISI Web of Knowledge to identify any later studies that may have cited it. </p> </li> <li> <p>Investigators were contacted through requests for information about unpublished trials.</p> </li> </ul> </p> <p>All searches included non English language literature, and studies with English language abstracts were assessed for inclusion. </p> </section> </section> <section id="CD009695-sec-0040"> <h3 class="title" id="CD009695-sec-0040">Data collection and analysis</h3> <section id="CD009695-sec-0041"> <h4 class="title">Selection of studies</h4> <p>One review author (CP‐M) inspected the search titles and abstracts. The full text of each potentially relevant article to be included in the review was requested, and two review authors assessed the studies independently for inclusion (CP‐M, XC). Doubts were discussed with all review authors if no agreement could be reached between the two assessors. </p> </section> <section id="CD009695-sec-0042"> <h4 class="title">Data extraction and management</h4> <p>From full papers, concrete information was extracted by two review authors (CP‐M, XC), who used a piloted data extraction sheet. Any disagreement was resolved by consensus and, if necessary, was discussed by all review authors. Study authors were contacted by e‐mail with requests for missing information on at least two different occasions. </p> </section> <section id="CD009695-sec-0043"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors assessed the risk of bias independently (CP‐M, XC), and if no agreement could be reached between them, doubts were discussed by all review authors. </p> <p>The risk of bias assessment for RCTs in this review was performed using the criteria recommended by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009695-bbs2-0051" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). The recommended approach for assessing risk of bias in studies included in a Cochrane review involves use of a two‐part tool to address specific domains, namely, sequence generation (selection bias),allocation concealment (selection bias), blinding of participants and providers (performance bias), blinding of outcome assessor (detection bias), incomplete outcome data (attrition bias), selective outcome reporting (reporting bias) and other sources of bias. The first part of the tool involves describing what was reported to have happened in the study. The second part of the tool involves assigning a judgement related to the risk of bias for that entry, in terms of low, high or unclear risk. To make these judgements, we used the criteria indicated by the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> as adapted for the field of addiction. See <a href="./appendices#CD009695-sec-0081">Appendix 6</a> for details. </p> <p>The domains of sequence generation,allocation concealment (avoidance of selection bias), and other sources of bias were addressed by the tool by a single entry for each study. </p> <p>Blinding of participants, personnel and outcome assessor (avoidance of performance bias and detection bias) was considered separately for objective outcomes (e.g. dropout, use of substance of abuse as measured by urinalysis) and subjective outcomes (e.g. participant self‐reported use of substance and side effects). </p> <p>Incomplete outcome data (avoidance of attrition bias) were considered for all outcomes except dropout from treatment, which very often is the primary outcome measure in trials on addiction. </p> </section> <section id="CD009695-sec-0044"> <h4 class="title">Measures of treatment effect</h4> <p>We used Review Manager 5.2 (RevMan) to perform the statistical analysis. We calculated mean difference (MD) using Hedges’ method for continuous outcomes and risk ratio (RR) for dichotomous ones. The risk difference (RD) was preferred over RR for outcomes such as dropouts due to any/cardiovascular/psychiatric adverse events if several studies were found to have 0 events for both psychostimulant and placebo groups, to avoid overestimation of treatment effect. Individual study weights were calculated as the inverse of the variance. </p> <p>Uncertainty of all measures was expressed by means of their 95% confidence intervals (CI). </p> </section> <section id="CD009695-sec-0045"> <h4 class="title">Unit of analysis issues</h4> <p>In studies with multiple and correlated interventions (e.g. studies with one control group and multiple experimental ones), the experimental groups were combined into a single group and were included in the meta‐analysis as a single pair‐wise comparison. This approach was used, for instance, when one study compared two different doses of a single psychostimulant drug against placebo. In this situation, both active intervention arms were combined, and only one comparison psychostimulant versus placebo was included in the meta‐analysis. For dichotomous outcomes, both the sample sizes and the numbers of people with events were summed across groups. For continuous outcomes, means and standard deviations were combined using the statistical formulae available in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009695-bbs2-0051" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD009695-sec-0046"> <h4 class="title">Dealing with missing data</h4> <p>The intention‐to‐treat (ITT) sample size was used as the denominator for categorical variables such as retention or sustained amphetamine abstinence. </p> <p>For continuous data, the sample size introduced in RevMan was the sample size used in each article to calculate that mean and SD. In cases of missing SDs, we used other information to determine them, such as confidence intervals, standard errors, <i>t</i>‐values, P‐values or F‐values as reported. If available information was insufficient, the SD was imputed from those available in other studies of the review (<a href="./references#CD009695-bbs2-0051" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD009695-sec-0047"> <h4 class="title">Assessment of heterogeneity</h4> <p>Heterogeneity was analysed by means of the I<sup>2</sup> statistic and the Chi<sup>2</sup> test for heterogeneity.The cut points were I<sup>2</sup> &gt; 50% and P of the Chi<sup>2</sup> test &lt; 0.1. </p> </section> <section id="CD009695-sec-0048"> <h4 class="title">Assessment of reporting biases</h4> <p>Funnel plots (plots of the effect estimate from each study against the standard error) were used to assess the potential for bias related to the size of the trials, which could indicate possible publication bias. If asymmetry was found, the Egger test (<a href="./references#CD009695-bbs2-0042" title="EggerM , SmithGD , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. British Medical Journal1997;315:629‐34. ">Egger 1997</a>) was conducted. </p> </section> <section id="CD009695-sec-0049"> <h4 class="title">Data synthesis</h4> <p>The outcomes of the individual trials were combined through meta‐analysis where possible (comparability of interventions and outcomes between trials) with the use of a random‐effects model, as some variability was expected in the studies included. </p> </section> <section id="CD009695-sec-0050"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>The following subgroup analyses were carried out. The pooled effect and between‐study heterogeneity were calculated within each subgroup. </p> <p> <ul id="CD009695-list-0015"> <li> <p>Type of studied psychostimulant: dextroamphetamine, modafinil, bupropion, etc.</p> </li> <li> <p>Type of amphetamine dependence: amphetamine, methamphetamine, MDMA, etc.</p> </li> <li> <p>Study length. The influence of study length was planned to be studied by means of bivariate random‐effects meta‐regression using the restricted maximum likelihood method if at least 10 studies were available (or by stratification in two groups according to the median study length). As most of the studies lasted 12 weeks, this subgroup analysis was not performed. </p> </li> <li> <p>Comorbidities as inclusion criteria (ADHD, opioid dependence, alcohol dependence, etc). </p> </li> <li> <p>Published versus unpublished data.</p> </li> <li> <p>Risk of bias of included studies, assessed by means of the Cochrane risk of bias instrument: high risk versus intermediate or low risk of bias in the domain Incomplete Outcome Data. (High‐risk studies were expected according to this domain, as attrition is high in drug dependence trials.) </p> </li> </ul> </p> </section> <section id="CD009695-sec-0051"> <h4 class="title">Sensitivity analysis</h4> <p>For safety outcomes, when studies with 0 events were identified and RD was used in the main analysis, a sensitivity analysis was carried out using the RR instead of the RD. Effects measured by the RR can be easily interpreted, although bias due to exclusion of studies with 0 events in this case cannot be ruled out. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009695-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009695-sec-0052"></div> <section id="CD009695-sec-0053"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD009695-sec-0089" title="">Characteristics of included studies</a>; <a href="./references#CD009695-sec-0090" title="">Characteristics of excluded studies</a>; and <a href="./references#CD009695-sec-0091" title="">Characteristics of ongoing studies</a>. </p> <section id="CD009695-sec-0054"> <h4 class="title">Results of the search</h4> <p>Despite all the reports obtained from the different databases, most were excluded after review authors read the title or the title and abstract. Twenty were retrieved in full text for more detailed evaluation. Of those 20, 9 studies were excluded and 11 met the inclusion criteria of this review. Seven studies are ongoing. See flow diagram in <a href="#CD009695-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD009695-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow diagram for selection of studies." data-id="CD009695-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram for selection of studies.</p> </div> </div> </div> </section> <section id="CD009695-sec-0055"> <h4 class="title">Included studies</h4> <p>Eleven studies were included in the review. Studies were conducted by university researchers with only one exception (<a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>), and pharmaceutical industry helped to fund three of them (<a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0009" title="ShearerJ , DarkeS , RodgersC , SladeT , vanBeekI , LewisJ , et al. A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction2009;104(2):224‐33. ">Shearer 2009</a>). </p> <p><b>Participants</b> </p> <p>A total of 791 participants were enrolled. Almost two‐thirds (64.9%) were male and had a mean age of 35.9 years. Nine studies (<a href="./references#CD009695-bbs2-0001" title="AndersonAL , LiSH , BiswasK , McSherryF , HolmesT , IturriagaE , et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2012;120(1‐3):135‐41. ">Anderson 2012</a>; <a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0003" title="ElkashefAM , RawsonRA , AndersonAL , LiSH , HolmesT , SmithEV , et al. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology2008;33(5):1162‐70. ">Elkashef 2008 a</a>; <a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0007" title="LongoM , WickesW , SmoutM , HarrisonS , CahillS , WhiteJM . Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction2010;105(1):146‐54. ">Longo 2010</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>; <a href="./references#CD009695-bbs2-0009" title="ShearerJ , DarkeS , RodgersC , SladeT , vanBeekI , LewisJ , et al. A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction2009;104(2):224‐33. ">Shearer 2009</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>) enrolled methamphetamine‐dependent participants, and two enrolled amphetamine‐dependent participants (<a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0011" title="TiihonenJ , KuoppasalmiK , FöhrJ , TuomolaP , KuikanmäkiO , VormaH , et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry2007;164(1):160‐2. ">Tiihonen 2007</a>). Duration of use ranged from 7 to 15.9 years, and 59% of participants used the drug intrapulmonarily (ip). Comorbid ADHD was rather prevalent amongst participants enrolled because this condition was an inclusion criterion in one study (<a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>). Conversely, other non‐nicotine dependencies were infrequent, probably because patients with these comorbid disorders were excluded. Indeed, only two studies enrolled opioid‐dependent participants (<a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>: 1 participant; <a href="./references#CD009695-bbs2-0009" title="ShearerJ , DarkeS , RodgersC , SladeT , vanBeekI , LewisJ , et al. A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction2009;104(2):224‐33. ">Shearer 2009</a>: 10 participants), and one included alcohol‐dependent participants (<a href="./references#CD009695-bbs2-0001" title="AndersonAL , LiSH , BiswasK , McSherryF , HolmesT , IturriagaE , et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2012;120(1‐3):135‐41. ">Anderson 2012</a>: 7 participants). Participants did not have psychotic disorders, and only one study included participants with major depression (<a href="./references#CD009695-bbs2-0001" title="AndersonAL , LiSH , BiswasK , McSherryF , HolmesT , IturriagaE , et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2012;120(1‐3):135‐41. ">Anderson 2012</a>: 15 participants). </p> <p>A detailed description of the baseline characteristics of participants included in these studies can be found in <a href="#CD009695-tbl-0002">Table 1</a>. </p> <div class="table" id="CD009695-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Baseline characteristics of the participants included in the RCT of the meta‐analysis</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sample size</b> </p> <p>n</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>791</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Gender</b> </p> <p>% male</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.9</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age</b> </p> <p>Mean age (years)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.9</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Race</b> </p> <p>% Caucasian</p> <p>% African‐American</p> <p>% Other</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70.5</p> <p>3.8</p> <p>25.7</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Employment status</b> </p> <p>% currently employed</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Type of dependence</b> </p> <p>% methamphetamine dependence</p> <p>% amphetamine dependence</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92.7</p> <p>7.3</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean days of use/month</b> </p> <p>Range</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.3‐19.5</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean length of amphetamine use (years)</b> </p> <p>Range of mean lifetime amphetamine use</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7‐15.9</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Route of use</b> </p> <p>% ip</p> <p>% iv</p> <p>% in</p> <p>% oral</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.0</p> <p>22.8</p> <p>17.6</p> <p>0.6</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comorbidities</b> </p> <p>% nicotine dependent</p> <p>% ADHD</p> <p>% opioid dependent</p> <p>% alcohol dependent</p> <p>% major depression</p> <p>% psychotic disorders</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.9</p> <p>13.9</p> <p>1.6</p> <p>1,1</p> <p>0.8</p> <p>0</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Abbreviations: ADHD = attention deficit hyperactivity disorder, ip = intrapulmonary, iv = intravenous, in = intranasal. Baseline participant characteristics are presented for those trials reporting this information. Gender, age and type of dependence were available for all studies, whereas opioid dependence and alcohol dependence from 9 studies, psychotic disorders and major depression from 8, employment status from 7, lifetime amphetamine use and ADHD from 6, race from 5 studies and nicotine dependence days of amphetamine use in a month and route of amphetamine use in 4. </p> </div> </div> <p><b>Interventions and settings</b> </p> <p>Four psychostimulants have been investigated for the treatment of amphetamine dependence, namely, modafinil, bupropion, dexamphetamine and methylphenidate. The most frequently studied psychostimulant was modafinil (4 studies: <a href="./references#CD009695-bbs2-0001" title="AndersonAL , LiSH , BiswasK , McSherryF , HolmesT , IturriagaE , et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2012;120(1‐3):135‐41. ">Anderson 2012</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>; <a href="./references#CD009695-bbs2-0009" title="ShearerJ , DarkeS , RodgersC , SladeT , vanBeekI , LewisJ , et al. A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction2009;104(2):224‐33. ">Shearer 2009</a>) followed by bupropion (3 studies: <a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0003" title="ElkashefAM , RawsonRA , AndersonAL , LiSH , HolmesT , SmithEV , et al. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology2008;33(5):1162‐70. ">Elkashef 2008 a</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>). Both dexamphetamine (<a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>; <a href="./references#CD009695-bbs2-0007" title="LongoM , WickesW , SmoutM , HarrisonS , CahillS , WhiteJM . Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction2010;105(1):146‐54. ">Longo 2010</a>) and methylphenidate (<a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0011" title="TiihonenJ , KuoppasalmiK , FöhrJ , TuomolaP , KuikanmäkiO , VormaH , et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry2007;164(1):160‐2. ">Tiihonen 2007</a>) were studied in two trials. </p> <p>Psychosocial interventions were provided in all studies, in addition to the study intervention. Cognitive‐behavioural therapy (CBT) was provided in five studies. CBT was the only psychological intervention provided in one study, but it was administered together with contingency management (CM) in three studies and with counselling and motivational enhancement therapy in the other two. The remaining seven studies provided one of the following psychotherapies: counselling, individual motivational psychotherapy, individual skills training program, unstructured psychosocial treatment, cognitive‐behavioural intervention or unspecified psychotherapy. Five studies were single site and five multiple site, and in one of them, the number of centres implied was not specified. More than half of the studies (seven studies) were conducted in the USA, two studies were conducted in Australia (<a href="./references#CD009695-bbs2-0007" title="LongoM , WickesW , SmoutM , HarrisonS , CahillS , WhiteJM . Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction2010;105(1):146‐54. ">Longo 2010</a>; <a href="./references#CD009695-bbs2-0009" title="ShearerJ , DarkeS , RodgersC , SladeT , vanBeekI , LewisJ , et al. A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction2009;104(2):224‐33. ">Shearer 2009</a>), one in Sweeden (<a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>) and one in Finland (<a href="./references#CD009695-bbs2-0011" title="TiihonenJ , KuoppasalmiK , FöhrJ , TuomolaP , KuikanmäkiO , VormaH , et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry2007;164(1):160‐2. ">Tiihonen 2007</a>). Study length ranged from 8 to 20 weeks, and most (seven) studies lasted for 12 weeks. </p> <p>All studies were conducted in an outpatient setting, as this was an inclusion criterion of the review. </p> </section> <section id="CD009695-sec-0056"> <h4 class="title">Excluded studies</h4> <p>Nine studies were excluded from the review (see <a href="./references#CD009695-sec-0090" title="">Characteristics of excluded studies</a> and <a href="#CD009695-fig-0001">Figure 1</a>). Five were re‐analyses or sub‐analyses of included studies (55.6%). In two, the intervention studied was not a psychostimulant to treat amphetamine dependence. Finally, one study was not a randomised controlled clinical trial (RCCT), and another did not include a placebo group. </p> </section> </section> <section id="CD009695-sec-0057"> <h3 class="title">Risk of bias in included studies</h3> <p>A detailed description of the risk of bias for each study can be found in the corresponding risk of bias tables (<a href="./references#CD009695-sec-0089" title="">Characteristics of included studies</a>). This information is summarised in <a href="#CD009695-fig-0002">Figure 2</a> and <a href="#CD009695-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD009695-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009695-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD009695-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009695-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p><b><i>Sequence generation</i> </b> </p> <p>All studies were RCTs with parallel design. The method used to generate a random sequence was well described or was obtained through contact with authors in all but one study (<a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>). </p> <section id="CD009695-sec-0058"> <h4 class="title">Allocation</h4> <p>Concealment of allocation was unclear in half of the studies (<a href="./references#CD009695-bbs2-0003" title="ElkashefAM , RawsonRA , AndersonAL , LiSH , HolmesT , SmithEV , et al. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology2008;33(5):1162‐70. ">Elkashef 2008 a</a>; <a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>; <a href="./references#CD009695-bbs2-0011" title="TiihonenJ , KuoppasalmiK , FöhrJ , TuomolaP , KuikanmäkiO , VormaH , et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry2007;164(1):160‐2. ">Tiihonen 2007</a>). </p> </section> <section id="CD009695-sec-0059"> <h4 class="title">Blinding</h4> <p>Classical psychostimulants such as dexamphetamine or methylphenidate have powerful behavioural effects that may jeopardise blinding when these drugs are compared with placebo (<a href="./references#CD009695-bbs2-0062" title="MartinWR , SloanJW , SapiraJD , JasinskiDR . Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology &amp; Therapeutics1971;12(2):245‐58. ">Martin 1971</a>; <a href="./references#CD009695-bbs2-0061" title="MakrisAP , RushCR , FrederichRC , TaylorAC , KellyTH . Behavioral and subjective effects of d‐amphetamine and modafinil in healthy adults. Experimental and Clinical Psychopharmacology2007;15(2):123‐33. ">Makris 2007</a>), leading to the possibility of both performance and detection bias. Performance bias arises from systematic differences between groups in the care provided. This type of bias can affect any study endpoint. For this reason, all outcomes assessed in this review in studies using those drugs were judged to have an unclear risk of performance bias. Blinding failure can also cause detection bias, which consists of systematic differences between groups in the the way study endpoints are measured. Objective outcomes were considered free of detection bias because assessment of these outcomes was considered not to be influenced by blinding failure. In studies with dexamphetamine and methylphenidate, the possibility that blinding failure could affect the assessment of subjective outcomes could not be ruled out; consequently, detection bias was rated "unclear" for subjective outcomes. In studies with bupropion and modafinil (mild psychostimulants), no differences between conditions (intervention and placebo) were reported when participants were asked to guess the medication they received (<a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0009" title="ShearerJ , DarkeS , RodgersC , SladeT , vanBeekI , LewisJ , et al. A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction2009;104(2):224‐33. ">Shearer 2009</a>). Therefore, we considered that blinding could be maintained in studies testing those medications. </p> </section> <section id="CD009695-sec-0060"> <h4 class="title">Incomplete outcome data</h4> <p>To address attrition bias, we collected for each study discontinuation rate, reasons for dropout with each treatment and statistical methods used for data imputation. The treatment discontinuation rate was low (&lt; 20%) in only two studies (<a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>), both of which were considered to have low attrition bias. For the remaining studies, the discontinuation rate was moderate (&gt; 20% to 50%) or high (&gt; 50%), and attrition bias was deemed "unclear" or "high" after the other factors mentioned above were considered. </p> </section> <section id="CD009695-sec-0061"> <h4 class="title">Selective reporting</h4> <p>The clinical trial protocol was available for most studies. Information about the design and about outcomes assessed (relevant protocol information) between the trial protocol and the article was identical in most of these studies; therefore, the risk of reporting bias was deemed to be low in all of them. However, in two cases, outcomes in the registered protocol were not the same as in the published report; therefore, the risk of selective reporting bias was considered to be unclear (<a href="./references#CD009695-bbs2-0003" title="ElkashefAM , RawsonRA , AndersonAL , LiSH , HolmesT , SmithEV , et al. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology2008;33(5):1162‐70. ">Elkashef 2008 a</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>). Another study had an unclear risk because the protocol was not available (<a href="./references#CD009695-bbs2-0007" title="LongoM , WickesW , SmoutM , HarrisonS , CahillS , WhiteJM . Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction2010;105(1):146‐54. ">Longo 2010</a>). </p> </section> <section id="CD009695-sec-0062"> <h4 class="title">Other potential sources of bias</h4> <p>Seven studies were free of other sources of bias. In one study, the risk of bias was deemed unclear because annual income was different between groups and participants were paid for participation (<a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>). In one study, ADHD was not balanced between groups (<a href="./references#CD009695-bbs2-0003" title="ElkashefAM , RawsonRA , AndersonAL , LiSH , HolmesT , SmithEV , et al. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology2008;33(5):1162‐70. ">Elkashef 2008 a</a>), another study terminated because of lack of funding (<a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>) and one was an interim analysis of a longer trial with age baseline differences (<a href="./references#CD009695-bbs2-0011" title="TiihonenJ , KuoppasalmiK , FöhrJ , TuomolaP , KuikanmäkiO , VormaH , et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry2007;164(1):160‐2. ">Tiihonen 2007</a>). For these reasons, the last three were considered to have high risk of bias. </p> </section> </section> <section id="CD009695-sec-0063"> <h3 class="title" id="CD009695-sec-0063">Effects of interventions</h3> <p>See: <a href="./full#CD009695-tbl-0001"><b>Summary of findings for the main comparison</b> Psychostimulants for amphetamine abuse or dependence</a> </p> <p><b><i>Efficacy primary outcomes</i> </b> </p> <p><b>Amphetamine use assessed by the mean (SD) of the proportion of amphetamine‐free UA across the study per participant</b> </p> <p><i>(01) Any psychostimulant vs placebo</i> </p> <p>Seven studies (<a href="./references#CD009695-bbs2-0001" title="AndersonAL , LiSH , BiswasK , McSherryF , HolmesT , IturriagaE , et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2012;120(1‐3):135‐41. ">Anderson 2012</a>; <a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>), 473 participants: MD ‐0.26 (95% CI ‐0.85 to 0.33); this result was not statistically significant, see <a href="./references#CD009695-fig-0008" title="">Analysis 1.1</a> </p> <p><b>Amphetamine use assessed by the mean (SD) concentration of amphetamine in hair analysis at the end of the study</b> </p> <p><i>(01) Any psychostimulant vs placebo</i> </p> <p>Only one study (<a href="./references#CD009695-bbs2-0007" title="LongoM , WickesW , SmoutM , HarrisonS , CahillS , WhiteJM . Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction2010;105(1):146‐54. ">Longo 2010</a>), 22 participants, assessed amphetamine use in hair: MD 0.53, 95% CI ‐6.02 to 7.08), the result was not statistically significant, see <a href="./references#CD009695-fig-0009" title="">Analysis 1.2</a> </p> <p><b>Sustained amphetamine abstinence. Number of participants who achieved at least 3 weeks of sustained abstinence</b> </p> <p><i>(01) Any psychostimulant vs placebo</i> </p> <p>Six studies (<a href="./references#CD009695-bbs2-0001" title="AndersonAL , LiSH , BiswasK , McSherryF , HolmesT , IturriagaE , et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2012;120(1‐3):135‐41. ">Anderson 2012</a>; <a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0003" title="ElkashefAM , RawsonRA , AndersonAL , LiSH , HolmesT , SmithEV , et al. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology2008;33(5):1162‐70. ">Elkashef 2008 a</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>), 559 participants: RR 1.12 (95% CI 0.84 to 1.49); this result was not statistically significant, see <a href="./references#CD009695-fig-0010" title="">Analysis 1.3</a> </p> <p><b><i>Efficacy secondary outcomes</i> </b> </p> <p><b>Self‐reported amphetamine use assessed by the mean (SD) of days of amphetamine use across the study</b> </p> <p><i>(01) Any psychostimulant vs placebo</i> </p> <p>Three studies (<a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0007" title="LongoM , WickesW , SmoutM , HarrisonS , CahillS , WhiteJM . Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction2010;105(1):146‐54. ">Longo 2010</a>; <a href="./references#CD009695-bbs2-0009" title="ShearerJ , DarkeS , RodgersC , SladeT , vanBeekI , LewisJ , et al. A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction2009;104(2):224‐33. ">Shearer 2009</a>), 133 participants: MD ‐0.81 (95% CI ‐6.16 to 4.54); this result was not statistically significant. High heterogeneity was found (I<sup>2</sup> = 55%); see <a href="./references#CD009695-fig-0011" title="">Analysis 1.4</a> </p> <p><b>Retention in treatment. Number of participants who completed treatment</b> </p> <p><i>(01) Any pschychostimulant vs placebo</i> </p> <p>This outcome was available from all eleven studies (791 participants): RR 1.01 (95% CI 0.90 to 1.14), the result was not statistically significant; see <a href="./references#CD009695-fig-0012" title="">Analysis 1.5</a> </p> <p><b>Craving</b> </p> <p><i>(01) Any psychostimulant vs placebo</i> </p> <p>Two studies (<a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>), 144 participants: SMD 0.07 (95% CI ‐0.44 to 0.59), the result was not statistically significant. High heterogeneity was found (I<sup>2</sup> = 59%); see <a href="./references#CD009695-fig-0013" title="">Analysis 1.6</a> </p> <p><b><i>Safety secondary outcomes</i> </b> </p> <p><b>Dropouts due to any adverse event</b> </p> <p><i>(01) Any psychostimulant vs placebo</i> </p> <p>Ten studies (<a href="./references#CD009695-bbs2-0001" title="AndersonAL , LiSH , BiswasK , McSherryF , HolmesT , IturriagaE , et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2012;120(1‐3):135‐41. ">Anderson 2012</a>; <a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0007" title="LongoM , WickesW , SmoutM , HarrisonS , CahillS , WhiteJM . Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction2010;105(1):146‐54. ">Longo 2010</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>; <a href="./references#CD009695-bbs2-0009" title="ShearerJ , DarkeS , RodgersC , SladeT , vanBeekI , LewisJ , et al. A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction2009;104(2):224‐33. ">Shearer 2009</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>; <a href="./references#CD009695-bbs2-0011" title="TiihonenJ , KuoppasalmiK , FöhrJ , TuomolaP , KuikanmäkiO , VormaH , et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry2007;164(1):160‐2. ">Tiihonen 2007</a>), 640 participants: RD 0.01 (95% CI ‐0.03 to 0.04); this result was not statistically significant; see <a href="./references#CD009695-fig-0014" title="">Analysis 1.7</a> </p> <p><b>Dropouts due to cardiovascular adverse events</b> </p> <p><i>(01) Any psychostimulant vs placebo</i> </p> <p>Eight studies (<a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0007" title="LongoM , WickesW , SmoutM , HarrisonS , CahillS , WhiteJM . Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction2010;105(1):146‐54. ">Longo 2010</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>;<a href="./references#CD009695-bbs2-0009" title="ShearerJ , DarkeS , RodgersC , SladeT , vanBeekI , LewisJ , et al. A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction2009;104(2):224‐33. ">Shearer 2009</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>; <a href="./references#CD009695-bbs2-0011" title="TiihonenJ , KuoppasalmiK , FöhrJ , TuomolaP , KuikanmäkiO , VormaH , et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry2007;164(1):160‐2. ">Tiihonen 2007</a>), 3700 participants: RD 0.01 (95% CI ‐0.03 to 0.04); this result was not statistically significant, see <a href="./references#CD009695-fig-0015" title="">Analysis 1.8</a> </p> <p><b>Dropouts due to psychiatric adverse events</b> </p> <p><i>(01) Any psychostimulant vs placebo</i> </p> <p>Seven studies (<a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0007" title="LongoM , WickesW , SmoutM , HarrisonS , CahillS , WhiteJM . Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction2010;105(1):146‐54. ">Longo 2010</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>; <a href="./references#CD009695-bbs2-0011" title="TiihonenJ , KuoppasalmiK , FöhrJ , TuomolaP , KuikanmäkiO , VormaH , et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry2007;164(1):160‐2. ">Tiihonen 2007</a>), 290 participants: RD ‐0.02 (95% CI ‐0.06 to 0.02); this result was not statistically significant; see <a href="./references#CD009695-fig-0016" title="">Analysis 1.9</a> </p> <p><b><i>Subgroup analyses</i> </b> </p> <p>Subgroup analyses are reported only for the main outcome of the review, "Amphetamine use (UA)", although this outcome did not show heterogeneity. Only two primary outcomes had statistical heterogeneity ("self‐reported use" and "craving"), but they involved only three and two studies, respectively, limiting the utility of a further analysis of the influence of moderating variables. Still, subgroup analyses of all outcomes were performed, all of which showed no differences between subgroups, for further details see <a href="./references#CD009695-fig-0018" title="">Analysis 2.2</a>; <a href="./references#CD009695-fig-0019" title="">Analysis 2.3</a>; <a href="./references#CD009695-fig-0020" title="">Analysis 2.4</a>; <a href="./references#CD009695-fig-0021" title="">Analysis 2.5</a>; <a href="./references#CD009695-fig-0022" title="">Analysis 2.6</a>; <a href="./references#CD009695-fig-0023" title="">Analysis 2.7</a>; <a href="./references#CD009695-fig-0024" title="">Analysis 2.8</a>; <a href="./references#CD009695-fig-0025" title="">Analysis 2.9</a>;<a href="./references#CD009695-fig-0027" title="">Analysis 3.2</a>; <a href="./references#CD009695-fig-0028" title="">Analysis 3.3</a>; <a href="./references#CD009695-fig-0029" title="">Analysis 3.4</a>; <a href="./references#CD009695-fig-0030" title="">Analysis 3.5</a>; <a href="./references#CD009695-fig-0031" title="">Analysis 3.6</a>; <a href="./references#CD009695-fig-0032" title="">Analysis 3.7</a>; <a href="./references#CD009695-fig-0033" title="">Analysis 3.8</a>; <a href="./references#CD009695-fig-0034" title="">Analysis 3.9</a>; <a href="./references#CD009695-fig-0036" title="">Analysis 4.2</a>; <a href="./references#CD009695-fig-0037" title="">Analysis 4.3</a>; <a href="./references#CD009695-fig-0038" title="">Analysis 4.4</a>; <a href="./references#CD009695-fig-0039" title="">Analysis 4.5</a>; <a href="./references#CD009695-fig-0040" title="">Analysis 4.6</a>; <a href="./references#CD009695-fig-0041" title="">Analysis 4.7</a>; <a href="./references#CD009695-fig-0042" title="">Analysis 4.8</a>; <a href="./references#CD009695-fig-0043" title="">Analysis 4.9</a>; <a href="./references#CD009695-fig-0045" title="">Analysis 5.2</a>; <a href="./references#CD009695-fig-0046" title="">Analysis 5.3</a>; <a href="./references#CD009695-fig-0047" title="">Analysis 5.4</a>; <a href="./references#CD009695-fig-0048" title="">Analysis 5.5</a>; <a href="./references#CD009695-fig-0049" title="">Analysis 5.6</a>; <a href="./references#CD009695-fig-0050" title="">Analysis 5.7</a>; <a href="./references#CD009695-fig-0051" title="">Analysis 5.8</a>; <a href="./references#CD009695-fig-0052" title="">Analysis 5.9</a>; <a href="./references#CD009695-fig-0054" title="">Analysis 6.2</a>; <a href="./references#CD009695-fig-0055" title="">Analysis 6.3</a>; <a href="./references#CD009695-fig-0056" title="">Analysis 6.4</a>; <a href="./references#CD009695-fig-0057" title="">Analysis 6.5</a>; <a href="./references#CD009695-fig-0058" title="">Analysis 6.6</a>; <a href="./references#CD009695-fig-0059" title="">Analysis 6.7</a>; <a href="./references#CD009695-fig-0060" title="">Analysis 6.8</a>; <a href="./references#CD009695-fig-0061" title="">Analysis 6.9</a> </p> <p><b>Amphetamine use assessed by the mean (SD) of the proportion of amphetamine‐free UA across the study per participant</b> </p> <p><i>(2) Subgroup analysis: type of drug</i> </p> <p>Bupropion vs placebo, two studies (<a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>), 103 participants: MD ‐1.52 (95% CI ‐4.20 to 1.17); this result was not statistically significant </p> <p>Dexamphetamine vs placebo, one study (<a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>), 60 participants: MD ‐0.30 (95% CI ‐2.66 to 2.06); this result was not statistically significant. </p> <p>Methylphenidate vs placebo, one study (<a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>), 24 participants: MD 1.50 (95% CI ‐4.24 to 7.24); this result was not statistically significant. </p> <p>Modafinil vs placebo, three studies (<a href="./references#CD009695-bbs2-0001" title="AndersonAL , LiSH , BiswasK , McSherryF , HolmesT , IturriagaE , et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2012;120(1‐3):135‐41. ">Anderson 2012</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>), 286 participants: MD ‐0.21 (95%CI ‐0.84 to 0.42); this result was not statistically significant. </p> <p>For all see <a href="./references#CD009695-fig-0017" title="">Analysis 2.1</a> </p> <p><i>(3) Subgroup analysis: type of dependence</i> </p> <p>Amphetamine dependence: psychostimulants vs placebo, one study (<a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>), 24 participants: MD 1.50 (95% CI ‐4.24 to 7.24); this result was not statistically significant. </p> <p>Methamphetamine dependence: psychostimulants vs placebo, six studies (<a href="./references#CD009695-bbs2-0001" title="AndersonAL , LiSH , BiswasK , McSherryF , HolmesT , IturriagaE , et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2012;120(1‐3):135‐41. ">Anderson 2012</a>; <a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>), 449 participants: MD ‐0.28 (95% CI ‐0.87 to 0.31); this result was not statistically significant. No heterogeneity was found. </p> <p>For both see <a href="./references#CD009695-fig-0026" title="">Analysis 3.1</a> </p> <p><i>(4) Subgroup analysis: comorbid ADHD as inclusion criterion</i> </p> <p>ADHD: psychostimulants vs placebo, one study (<a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>), 24 participants: MD 1.50 (95% CI ‐4.24 to 7.24); this result was not statistically significant. </p> <p>No ADHD: psychostimulants vs placebo, six studies (<a href="./references#CD009695-bbs2-0001" title="AndersonAL , LiSH , BiswasK , McSherryF , HolmesT , IturriagaE , et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2012;120(1‐3):135‐41. ">Anderson 2012</a>; <a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>), 449 participants: MD ‐0.28 (95% CI ‐0.87 to 0.31); this result was not statistically significant. No heterogeneity was found. </p> <p>For both see <a href="./references#CD009695-fig-0035" title="">Analysis 4.1</a> </p> <p><i>(5) Subgroup analysis: data publication</i> </p> <p>Published data: psychostimulants vs placebo, three studies (<a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>), 138 participants: MD 0.22 (95% CI ‐0.83 to 0.39); this result was not statistically significant. </p> <p>Unpublished data: psychostimulants vs placebo, four studies (<a href="./references#CD009695-bbs2-0001" title="AndersonAL , LiSH , BiswasK , McSherryF , HolmesT , IturriagaE , et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2012;120(1‐3):135‐41. ">Anderson 2012</a>; <a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>), 335 participants: MD ‐0.86 (95% CI ‐3.21 to 1.50); this result was not statistically significant. </p> <p>For both see <a href="./references#CD009695-fig-0044" title="">Analysis 5.1</a> </p> <p><i>(6) Subgroup analysis: clinical trial reporting quality (incomplete outcome data)</i> </p> <p>Low or intermediate risk of bias: psychostimulants vs placebo, three studies (<a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>; <a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>), 114 participants: MD ‐0.79 (95% CI ‐2.55 to 0.98); this result was not statistically significant. </p> <p>High risk of bias: psychostimulants vs placebo, one study (<a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>), 5 participants: MD ‐0.19, 95% CI‐0.82 to 0.43); this result was not statistically significant. </p> <p>For both see <a href="./references#CD009695-fig-0053" title="">Analysis 6.1</a> </p> <p>We planned to determine the influence of study length over treatment outcomes. Nevertheless, we could not finally run this analysis because between‐study variability of this co‐variable was not large enough. Indeed, most studies (7 out of 11) had the same study length (12 weeks). </p> <p><b><i>Reporting bias analyses</i> </b> </p> <p>Funnel plots of the efficacy primary outcomes were drawn (<a href="#CD009695-fig-0004">Figure 4</a>; <a href="#CD009695-fig-0005">Figure 5</a>), with the exception of amphetamine use as assessed in hair (only one study assessed that). A funnel plot was also performed for one of the most relevant outcomes of this kind of study: "retention in treatment" (<a href="#CD009695-fig-0006">Figure 6</a>). None showed asymmetry suggestive of reporting bias. </p> <div class="figure" id="CD009695-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Psychostimulants vs placebo for amphetamine dependence, outcome: 1.1 Amphetamine use (UA)." data-id="CD009695-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Psychostimulants vs placebo for amphetamine dependence, outcome: 1.1 Amphetamine use (UA). </p> </div> </div> </div> <div class="figure" id="CD009695-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Psychostimulants vs placebo for amphetamine dependence, outcome: 1.3 Sustained abstinence." data-id="CD009695-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Psychostimulants vs placebo for amphetamine dependence, outcome: 1.3 Sustained abstinence. </p> </div> </div> </div> <div class="figure" id="CD009695-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: 1 Psychostimulants vs placebo for amphetamine dependence, outcome: 1.5 Retention in treatment." data-id="CD009695-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Psychostimulants vs placebo for amphetamine dependence, outcome: 1.5 Retention in treatment. </p> </div> </div> </div> <p>Reporting bias could also arise as the result of selective outcome reporting. To explore this, a subgroup analysis was performed while taking into account whether or not data were published (or obtained from authors), and, as mentioned previously, the effect of the intervention was similar in both subgroups. </p> <p><b><i>Sensitivity analyses</i> </b> </p> <p>The sensitivity analysis of the outcome "dropouts due to any adverse event" was conducted while excluding three studies with 0 events from the primary analysis (<a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>; <a href="./references#CD009695-bbs2-0011" title="TiihonenJ , KuoppasalmiK , FöhrJ , TuomolaP , KuikanmäkiO , VormaH , et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry2007;164(1):160‐2. ">Tiihonen 2007</a>). Therefore, seven studies were included (<a href="./references#CD009695-bbs2-0001" title="AndersonAL , LiSH , BiswasK , McSherryF , HolmesT , IturriagaE , et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2012;120(1‐3):135‐41. ">Anderson 2012</a>; <a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0007" title="LongoM , WickesW , SmoutM , HarrisonS , CahillS , WhiteJM . Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction2010;105(1):146‐54. ">Longo 2010</a>; <a href="./references#CD009695-bbs2-0009" title="ShearerJ , DarkeS , RodgersC , SladeT , vanBeekI , LewisJ , et al. A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction2009;104(2):224‐33. ">Shearer 2009</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>), 567 participants: RR 1.18 (95% CI 0.63 to 2.20); this result was not statistically significant, see <a href="./references#CD009695-fig-0062" title="">Analysis 7.1</a> </p> <p>The sensitivity analysis of the outcome "dropouts due to cardiovascular adverse events" was conducted while excluding five studies with 0 events from the primary analysis (<a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>;<a href="./references#CD009695-bbs2-0009" title="ShearerJ , DarkeS , RodgersC , SladeT , vanBeekI , LewisJ , et al. A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction2009;104(2):224‐33. ">Shearer 2009</a>; <a href="./references#CD009695-bbs2-0011" title="TiihonenJ , KuoppasalmiK , FöhrJ , TuomolaP , KuikanmäkiO , VormaH , et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry2007;164(1):160‐2. ">Tiihonen 2007</a>). Therefore, three studies were included (<a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0007" title="LongoM , WickesW , SmoutM , HarrisonS , CahillS , WhiteJM . Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction2010;105(1):146‐54. ">Longo 2010</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>), 193 participants: RR 1.50 (95% CI 0.30 to 7.58); this result was not statistically significant, see <a href="./references#CD009695-fig-0063" title="">Analysis 7.2</a> </p> <p>The sensitivity analysis of the outcome "dropouts due to psychiatric adverse events" was conducted while excluding three studies with 0 events from the primary analysis (<a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>; <a href="./references#CD009695-bbs2-0011" title="TiihonenJ , KuoppasalmiK , FöhrJ , TuomolaP , KuikanmäkiO , VormaH , et al. A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. Am J Psychiatry2007;164(1):160‐2. ">Tiihonen 2007</a>). Therefore, four studies were included (<a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0007" title="LongoM , WickesW , SmoutM , HarrisonS , CahillS , WhiteJM . Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction2010;105(1):146‐54. ">Longo 2010</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>), 217 participants: RR 0.62 (95% CI 0.13 to 2.99); this result was not statistically significant, see <a href="./references#CD009695-fig-0064" title="">Analysis 7.3</a> </p> <p><b><i>Post hoc analysis</i> </b> </p> <p>Two studies (<a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>) had a relapse prevention approach, and the remaining studies had a maintenance treatment approach. In <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>, participants completed 2 weeks of residential phase treatment to achieve initial abstinence before the outpatient phase. In <a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>, participants were required to stay abstinent 2 weeks before inclusion. </p> <p>A post hoc analysis was performed by splitting the available trials into two subgroups: maintenance versus relapse prevention treatment. No differences were found between psychostimulants and placebo in any of both subgroups for any outcome, as in the primary analysis. We present only data for the outcome "Amphetamine use (UA)". </p> <p>Subcategory 01: maintenance: psychostimulants vs placebo, five studies (<a href="./references#CD009695-bbs2-0001" title="AndersonAL , LiSH , BiswasK , McSherryF , HolmesT , IturriagaE , et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2012;120(1‐3):135‐41. ">Anderson 2012</a>; <a href="./references#CD009695-bbs2-0002" title="DasM , SantosD , MathesonT , SantosGM , ChuP , VittinghoffE , et al. Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high‐risk men who have sex with men. AIDS2010;24(7):991‐1000. ">Das 2009</a>; <a href="./references#CD009695-bbs2-0004" title="GallowayGP , BuscemiR , CoyleJR , FlowerK , SiegristJD , FiskeLA , et al. A randomized, placebo‐controlled trial of sustained‐release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther2011;89(2):276‐82. ">Galloway 2011</a>; <a href="./references#CD009695-bbs2-0005" title="HeinzerlingKG , SwansonAN , KimS , CederblomL , MoeA , LingW , ShoptawS . Randomized, double‐blind, placebo‐controlled trial of modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend2010;109(1‐3):20‐9. ">Heinzerling 2010</a>; <a href="./references#CD009695-bbs2-0010" title="ShoptawS , HeinzerlingKG , Rotheram‐FullerE , StewardT , WangJ , SwansonAN , et al. Randomized, placebo‐controlled trial of bupropion for the treatment of methamphetamine dependence. Drug Alcohol Depend2008;96(3):222‐32. ">Shoptaw 2008</a>), 444 participants: MD ‐0.62 (95% CI ‐2.29 to 1.06); this result was not statistically significant, </p> <p>Subcategory 02: relapse prevention: psychostimulants vs placebo, two studies (<a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>; <a href="./references#CD009695-bbs2-0008" title="MancinoM . Modafinil for methamphetamine dependence. Clinicaltrials.gov (NCT00859573). Results published in April 15, 2011. ">Mancino 2011</a>), 29 participants: ‐MD 0.21, 95% CI ‐0.84 to 0.42); this result was not statistically significant. </p> <p>For both see see <a href="./references#CD009695-fig-0065" title="">Analysis 8.1</a><a href="#CD009695-fig-0007">Figure 7</a>; </p> <div class="figure" id="CD009695-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 8 Post hoc analysis, outcome: 8.1 Amphetamine use (UA)." data-id="CD009695-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 8 Post hoc analysis, outcome: 8.1 Amphetamine use (UA).</p> </div> </div> </div> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009695-sec-0064" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009695-sec-0064">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009695-sec-0106">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009695-sec-0064"></div> <section id="CD009695-sec-0065"> <h3 class="title" id="CD009695-sec-0065">Summary of main results</h3> <p>During recent years, several psychostimulants have been tested to treat amphetamine dependence. The objective of this systematic review was to summarise available evidence of the use of psychostimulants in amphetamine abusers or dependents. It was found that psychostimulant maintenance for amphetamine dependence has been infrequently studied, as shown by the fact that only 11 clinical trials (791 participants) investigating four drugs with psychostimulant effect have been carried out. Neither psychostimulants as a group nor any single drug was found to reduce amphetamine use (by means of UA), attain sustained amphetamine abstinence or improve treatment retention. Only two studies individually showed a favourable result for one outcome (<a href="./references#CD009695-bbs2-0007" title="LongoM , WickesW , SmoutM , HarrisonS , CahillS , WhiteJM . Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence. Addiction2010;105(1):146‐54. ">Longo 2010</a>: retention improved with dexamphetamine; <a href="./references#CD009695-bbs2-0009" title="ShearerJ , DarkeS , RodgersC , SladeT , vanBeekI , LewisJ , et al. A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction2009;104(2):224‐33. ">Shearer 2009</a>: self‐reported use improved with modafinil). Data for anxiety symptoms, depressive symptoms and overall functioning could not be meta‐analysed because they were not reported in a way that allowed aggregation. </p> <p>Regarding safety, no statistically significant differences between psychostimulants and placebo were found in the dropout rate due to AEs. This finding suggests that psychostimulants are well tolerated by amphetamine‐dependent patients. It must be noted that this safety outcome is rather unspecific because it provides no information on the type of AE that causes treatment discontinuation. However, the way AEs are usually reported in clinical trials shows large between‐study heterogeneity, precluding the possibility of pooling together the results of specific types of AEs from different studies. Furthermore, mild and transient side effects that do not cause participants to discontinue treatment are not included in this safety outcome; therefore, our review cannot rule out the possibility that the rate of this type of AE is different between psychostimulants and placebo. It is interesting to note that no cases of study medication abuse were reported in the included trials; this is one of the main concerns when psychostimulants are used to treat amphetamine‐dependent patients. </p> <p>A series of subgroup analyses was performed and showed that results were consistent across all of them. No differences in efficacy, safety and retention were found between psychostimulants and placebo on any of these analyses. Grouping the included RCCTs into different categories in the subgroup analysis did not result in any difference in the main analysis, probably because no heterogeneity to be explained was previously found. It should be taken into account that in the subgroup analysis performed, we studied the effects of the intervention within the planned subgroups, but we did not compare the effects of the intervention between the different subgroups because this was not the aim of this systematic review. </p> <p>With the available data at this moment, it seems that although it is effective in treating nicotine and opiate dependence, replacement therapy does not seem to be useful for treating amphetamine dependence. This finding contrasts with those of psychostimulant maintenance for cocaine dependence, for which hopeful results were found on cocaine abstinence, particularly in methadone‐maintained dual opioid‐cocaine－dependent participants (<a href="./references#CD009695-bbs2-0034" title="CastellsX , CasasM , Pérez‐MañáC , RonceroC , VidalX , CapellàD . Efficacy of Psychostimulant Drugs for Cocaine Dependence. Cochrane Database of Systematic Reviews2010, Issue 2. [DOI: 10.1002/14651858.CD007380.pub3] ">Castells 2010</a>). The fact that these participants were receiving methadone enabled that study retention was high. Conversely, the retention rate in most studies included in the present review was relatively low; therefore, treatment compliance was also low, and so it was not possible to demonstrate the therapeutic effect of the studied intervention. </p> <p>It should be kept in mind that the results of this meta‐analysis have been obtained with only a few studies with small sample sizes, undertaken to test psychostimulants with different stimulant potencies (strong psychostimulants like dexamphetamine and methylphenidate and mild psychostimulants like bupropion and modafinil) and restricted ranges of doses. </p> </section> <section id="CD009695-sec-0066"> <h3 class="title" id="CD009695-sec-0066">Overall completeness and applicability of evidence</h3> <p>The external validity of the review is limited by the inclusion/exclusion criteria of the studies. Studies were conducted in the USA, Australia or Northern Europe. Generalisation of the results to other countries should be made with caution because social, cultural and health system differences can actively affect the overall treatment outcome. Furthermore, most studies included participants dependent upon methamphetamine because amphetamine dependence is rather infrequent. In all studies, participants were dependent on amphetamine‐type stimulants (amphetamine or methamphetamine), and no abusers were included. It is likely that the results obtained for methamphetamine‐dependent participants can be extrapolated to amphetamine‐dependent participants because, as was mentioned previously, these drugs have similar physiological and behavioural effects (<a href="./references#CD009695-bbs2-0062" title="MartinWR , SloanJW , SapiraJD , JasinskiDR . Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology &amp; Therapeutics1971;12(2):245‐58. ">Martin 1971</a>). </p> <p>Regarding MDMA, some important differences arise when it is compared with methamphetamine. MDMA has higher SERT selectivity, but methamphetamine acts mainly in the catecholamine transporters: NET and DAT (<a href="./references#CD009695-bbs2-0029" title="BaumannMH , AyestasMAJr , PartillaJS , SinkJR , ShulginAT , DaleyPF , et al. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.. Neuropsychopharmacology2012;37:1192‐203. ">Baumann 2012</a>). In physiological and behavioural terms, MDMA displays similarities to methamphetamine (<a href="./references#CD009695-bbs2-0055" title="KirkpatrickMG , GundersonEW , PerezAY , HaneyM , FoltinRW , HartCL . A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4‐methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology2012;219:109‐22. ">Kirkpatrick 2012 a</a>), but the dependence syndrome for ecstasy may not be of the same nature as for the other amphetamine‐type stimulants (<a href="./references#CD009695-bbs2-0039" title="DegenhardtL , BrunoR , ToppL . Is ecstasy a drug of dependence?. Drug and Alcohol Dependence2010;107:1‐10. ">Degenhardt 2010</a>). Therefore, in our opinion, the results of this review should not be extrapolated to ecstasy‐dependent patients. </p> <p>Finally, it must be noted that the representativeness of participants included in this systematic review is relatively low, fundamentally because patients with comorbid psychiatric disorders (major depression, psychotic disorders, other drug dependences) were usually excluded from the included trials, but comorbidities were frequent amongst amphetamine‐dependent clinical samples (<a href="./references#CD009695-bbs2-0046" title="Glasner‐EdwardsS , MooneyLJ , Marinelli‐CaseyP , HillhouseM , AngA , RawsonRA , Methamphetamine Treatment Project Corporate Authors. Psychopathology in methamphetamine‐dependent adults 3 years after treatment. Drug and Alcohol Reviews2010;29:12‐20. ">Glasner‐Edwards 2010</a>; <a href="./references#CD009695-bbs2-0071" title="SaloR , FlowerK , KielsteinA , LeamonMH , NordahlTE , GallowayGP . Psychiatric comorbidity in methamphetamine dependence. Psychiatry Research2011;186(2‐3):356‐61. ">Salo 2011</a>). In fact, in only one study, other dependencies or psychiatric comorbidities were an inclusion criterion (ADHD: <a href="./references#CD009695-bbs2-0006" title="KonsteniusM , Jayaram‐LindströmN , BeckO , FranckJ . Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study. Drug Alcohol Depend2010;108(1‐2):130‐3. ">Konstenius 2010</a>). It must be acknowledged that it is unlikely that psychostimulants could be efficacious in treating dual‐dependent patients when they have not proved so in selected samples. </p> </section> <section id="CD009695-sec-0067"> <h3 class="title" id="CD009695-sec-0067">Quality of the evidence</h3> <p>To grade the quality of evidence, a summary of findings table was prepared using the GRADE methodology. </p> <p>Evidence was classified as very low for the outcomes "amphetamine use (UA)" and "sustained abstinence". Evidence was downgraded in both cases because of risk of bias (mainly for high attrition), imprecision of results obtained and indirectness. The imprecision and therefore the wide 95% CI calculated are consequences of the limited number of included studies and the small sample size in all of them. Furthermore, no included trial reported adequate allocation concealment, so it is unclear whether foreknowledge of the forthcoming allocations was prevented. Finally, attrition was high in most of the studies, and so was the possibility of bias due to incomplete outcome data (high risk or unclear in all but two studies). In our opinion, the high attrition in the included studies further reduces confidence in the results obtained for amphetamine use. We consider that reasons for missing data in addiction trials are likely to be related to true outcome. Indirectness arises from the fact that we pooled together the results of studies that investigated different drugs and doses. To our knowledge, no study has yet investigated the pharmacodynamic equivalence between psychostimulants; therefore the presence of a dose‐response relationship could not be investigated. Classifiying evidence as very low denotes that we are highly uncertain about the estimate calculated. Therefore, the publication of any new study could change substantially the results and conclusions of this review. </p> <p>Evidence was classified as low for "retention in treatment". In this case, evidence was downgraded only as the result of indirectness and inconsistency because no risk of bias due to high attrition was associated with this outcome. Rating the evidence as low indicates that our confidence in the results of our review in terms of this outcome is poor. Thus, future research is likely to change the pooled estimate as calculated. </p> </section> <section id="CD009695-sec-0068"> <h3 class="title" id="CD009695-sec-0068">Potential biases in the review process</h3> <p>Reporting bias can jeopardise the validity of any meta‐analysis. We have tried to limit the influence of reporting bias by screening several data sets and requesting unpublished results from the contact authors. Indeed in this review, a considerable quantity of unpublished data was included after authors of the studies had been contacted (data from 10 of 11 studies). We have also carried out funnel plots for the outcomes "amphetamine use (UA)", "sustained abstinence" and "retention in treatment", and they do not suggest publication bias. Nevertheless, it must be noted that the number of studies included in this review was low, and so it was the sensitivity of the funnel plot that was used to identify the possibility of publication bias. </p> <p>A subgroup analysis was conducted that took into account whether or not the data used were published. When published and unpublished data were compared, no differences were found, providing additional support for the lack of publication bias. </p> <p>The fact that all studies were funded by public institutions may explain why studies with negative findings were published. </p> </section> <section id="CD009695-sec-0069"> <h3 class="title" id="CD009695-sec-0069">Agreements and disagreements with other studies or reviews</h3> <p>Several narrative reviews, including those on psychostimulant medications, are available (<a href="./references#CD009695-bbs2-0031" title="BrackinsT , BrahmNC , KissackJC . Treatments for methamphetamine abuse: a literature review for the clinician. J Pharm Pract2011;24(6):541‐50. ">Brackins 2011</a>; <a href="./references#CD009695-bbs2-0044" title="ElkashefA , VocciF , HansonG , WhiteJ , WickesW , TiihonenJ . Pharmacotherapy of methamphetamine addiction: an update. Substance Abuse2008;29(3):31‐49. ">Elkashef 2008 b</a>; <a href="./references#CD009695-bbs2-0050" title="HerinDV , RushCR , GrabowskiJ . Agonist‐like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Annals of the New York Academy of Sciences2010;1178:76‐100. ">Herin 2010</a>; <a href="./references#CD009695-bbs2-0053" title="KarilaL , WeinsteinA , AubinHJ , BenyaminaA , ReynaudM , BatkiSL . Pharmacological approaches to methamphetamine dependence: a focused review. Bristish Journal of Clinical Pharmacology2010;69(6):578‐92. ">Karila 2010</a>; <a href="./references#CD009695-bbs2-0064" title="MoellerFG , SchmitzJM , HerinD , KjomeKL . Use of stimulants to treat cocaine and methamphetamine abuse. Current Psychiatry Report2008;10(5):385‐91. ">Moeller 2008</a>; <a href="./references#CD009695-bbs2-0073" title="ShearerJ . The principles of agonist pharmacotherapy for psychostimulant dependence. Drug and Alcohol Reviews2008;27(3):301‐8. ">Shearer 2008</a>), but only one previous systematic review and meta‐analysis has been identified (<a href="./references#CD009695-bbs2-0068" title="Pérez‐MañáC , CastellsX , VidalX , CasasM , CapellàD . Efficacy of indirect dopamine agonists for psychostimulant dependence: a systematic review and meta‐analysis of randomized controlled trials. The Journal of Substance Abuse Treatment2011;40(2):109‐22. ">Pérez‐Mañá 2011</a>). This previous study assessed the efficacy of indirect dopamine agonists (some of them psychostimulants) in comparison with placebo for cocaine or amphetamine dependence. It showed favourable results only in cocaine‐dependent participants. In that moment, only four studies conducted in amphetamine‐dependent participants were available (all of them are included in this review). Performing the search three years later has led to the retrieval of seven additional studies. Although the statistical power of this review is greater than in the previous one (<a href="./references#CD009695-bbs2-0068" title="Pérez‐MañáC , CastellsX , VidalX , CasasM , CapellàD . Efficacy of indirect dopamine agonists for psychostimulant dependence: a systematic review and meta‐analysis of randomized controlled trials. The Journal of Substance Abuse Treatment2011;40(2):109‐22. ">Pérez‐Mañá 2011</a>) (11 studies vs 4 studies and 791 participants vs 357 participants), similar conclusions have been reached: Evidence in randomised clinical trials still does not support the use of psychostimulants for amphetamine dependence. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009695-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Flow diagram for selection of studies." data-id="CD009695-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow diagram for selection of studies.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009695-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009695-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Psychostimulants vs placebo for amphetamine dependence, outcome: 1.1 Amphetamine use (UA)." data-id="CD009695-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Psychostimulants vs placebo for amphetamine dependence, outcome: 1.1 Amphetamine use (UA). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Psychostimulants vs placebo for amphetamine dependence, outcome: 1.3 Sustained abstinence." data-id="CD009695-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Psychostimulants vs placebo for amphetamine dependence, outcome: 1.3 Sustained abstinence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: 1 Psychostimulants vs placebo for amphetamine dependence, outcome: 1.5 Retention in treatment." data-id="CD009695-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Funnel plot of comparison: 1 Psychostimulants vs placebo for amphetamine dependence, outcome: 1.5 Retention in treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 8 Post hoc analysis, outcome: 8.1 Amphetamine use (UA)." data-id="CD009695-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 8 Post hoc analysis, outcome: 8.1 Amphetamine use (UA).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 1 Amphetamine use (UA)." data-id="CD009695-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 1 Amphetamine use (UA). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 2 Amphetamine use (hair analysis)." data-id="CD009695-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 2 Amphetamine use (hair analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-001-03.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 3 Sustained abstinence." data-id="CD009695-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 3 Sustained abstinence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 4 Self‐reported amphetamine use." data-id="CD009695-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 4 Self‐reported amphetamine use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-001-05.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 5 Retention in treatment." data-id="CD009695-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 5 Retention in treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 6 Amphetamine craving." data-id="CD009695-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 6 Amphetamine craving. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 7 Dropouts due to any adverse event." data-id="CD009695-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 7 Dropouts due to any adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 8 Dropouts due to cardiovascular adverse events." data-id="CD009695-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 8 Dropouts due to cardiovascular adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 9 Dropouts due to psychiatric adverse events." data-id="CD009695-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Psychostimulants vs placebo for amphetamine dependence, Outcome 9 Dropouts due to psychiatric adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis: type of drug, Outcome 1 Amphetamine use (UA)." data-id="CD009695-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis: type of drug, Outcome 1 Amphetamine use (UA).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis: type of drug, Outcome 2 Amphetamine use (hair analysis)." data-id="CD009695-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis: type of drug, Outcome 2 Amphetamine use (hair analysis).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis: type of drug, Outcome 3 Sustained abstinence." data-id="CD009695-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis: type of drug, Outcome 3 Sustained abstinence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis: type of drug, Outcome 4 Self‐reported amphetamine use." data-id="CD009695-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis: type of drug, Outcome 4 Self‐reported amphetamine use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis: type of drug, Outcome 5 Retention in treatment." data-id="CD009695-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis: type of drug, Outcome 5 Retention in treatment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-002-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-002-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis: type of drug, Outcome 6 Amphetamine craving." data-id="CD009695-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis: type of drug, Outcome 6 Amphetamine craving.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-002-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-002-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis: type of drug, Outcome 7 Dropouts due to any adverse event." data-id="CD009695-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis: type of drug, Outcome 7 Dropouts due to any adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-002-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-002-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis: type of drug, Outcome 8 Dropouts due to cardiovascular adverse events." data-id="CD009695-fig-0024" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis: type of drug, Outcome 8 Dropouts due to cardiovascular adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Subgroup analysis: type of drug, Outcome 9 Dropouts due to psychiatric adverse events." data-id="CD009695-fig-0025" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Subgroup analysis: type of drug, Outcome 9 Dropouts due to psychiatric adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis: type of dependence, Outcome 1 Amphetamine use (UA)." data-id="CD009695-fig-0026" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis: type of dependence, Outcome 1 Amphetamine use (UA).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis: type of dependence, Outcome 2 Amphetamine use (hair analysis)." data-id="CD009695-fig-0027" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis: type of dependence, Outcome 2 Amphetamine use (hair analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis: type of dependence, Outcome 3 Sustained abstinence." data-id="CD009695-fig-0028" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis: type of dependence, Outcome 3 Sustained abstinence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis: type of dependence, Outcome 4 Self‐reported amphetamine use." data-id="CD009695-fig-0029" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis: type of dependence, Outcome 4 Self‐reported amphetamine use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis: type of dependence, Outcome 5 Retention in treatment." data-id="CD009695-fig-0030" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis: type of dependence, Outcome 5 Retention in treatment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis: type of dependence, Outcome 6 Amphetamine craving." data-id="CD009695-fig-0031" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis: type of dependence, Outcome 6 Amphetamine craving.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis: type of dependence, Outcome 7 Dropouts due to any adverse event." data-id="CD009695-fig-0032" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis: type of dependence, Outcome 7 Dropouts due to any adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis: type of dependence, Outcome 8 Dropouts due to cardiovascular adverse events." data-id="CD009695-fig-0033" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis: type of dependence, Outcome 8 Dropouts due to cardiovascular adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Subgroup analysis: type of dependence, Outcome 9 Dropouts due to psychiatric adverse events." data-id="CD009695-fig-0034" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Subgroup analysis: type of dependence, Outcome 9 Dropouts due to psychiatric adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 1 Amphetamine use (UA)." data-id="CD009695-fig-0035" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 1 Amphetamine use (UA). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 2 Amphetamine use (hair analysis)." data-id="CD009695-fig-0036" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 2 Amphetamine use (hair analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 3 Sustained abstinence." data-id="CD009695-fig-0037" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 3 Sustained abstinence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 4 Self reported amphetamine use." data-id="CD009695-fig-0038" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 4 Self reported amphetamine use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 5 Retention in treatment." data-id="CD009695-fig-0039" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 5 Retention in treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-004-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-004-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 6 Amphetamine craving." data-id="CD009695-fig-0040" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 6 Amphetamine craving. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-004-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-004-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 7 Dropouts due to any adverse event." data-id="CD009695-fig-0041" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 7 Dropouts due to any adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 8 Dropouts due to cardiovascular adverse events." data-id="CD009695-fig-0042" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 8 Dropouts due to cardiovascular adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-004-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-004-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 9 Dropouts due to psychiatric adverse events." data-id="CD009695-fig-0043" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.9</div> <div class="figure-caption"> <p>Comparison 4 Subgroup analysis: comorbid ADHD as inclusion criterion, Outcome 9 Dropouts due to psychiatric adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-004-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup analysis: data publication, Outcome 1 Amphetamine use (UA)." data-id="CD009695-fig-0044" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Subgroup analysis: data publication, Outcome 1 Amphetamine use (UA).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup analysis: data publication, Outcome 2 Amphetamine use (hair analysis)." data-id="CD009695-fig-0045" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Subgroup analysis: data publication, Outcome 2 Amphetamine use (hair analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup analysis: data publication, Outcome 3 Sustained abstinence." data-id="CD009695-fig-0046" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Subgroup analysis: data publication, Outcome 3 Sustained abstinence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup analysis: data publication, Outcome 4 Self reported amphetamine use." data-id="CD009695-fig-0047" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Subgroup analysis: data publication, Outcome 4 Self reported amphetamine use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup analysis: data publication, Outcome 5 Retention in treatment." data-id="CD009695-fig-0048" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Subgroup analysis: data publication, Outcome 5 Retention in treatment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup analysis: data publication, Outcome 6 Amphetamine craving (at the end of study)." data-id="CD009695-fig-0049" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Subgroup analysis: data publication, Outcome 6 Amphetamine craving (at the end of study). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup analysis: data publication, Outcome 7 Dropouts due to any adverse event." data-id="CD009695-fig-0050" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Subgroup analysis: data publication, Outcome 7 Dropouts due to any adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup analysis: data publication, Outcome 8 Dropouts due to cardiovascular adverse events." data-id="CD009695-fig-0051" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Subgroup analysis: data publication, Outcome 8 Dropouts due to cardiovascular adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-005-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-005-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Subgroup analysis: data publication, Outcome 9 Dropouts due to psychiatric adverse events." data-id="CD009695-fig-0052" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Subgroup analysis: data publication, Outcome 9 Dropouts due to psychiatric adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-005-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 1 Amphetamine use (UA)." data-id="CD009695-fig-0053" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 1 Amphetamine use (UA). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 2 Amphetamine use (hair analysis)." data-id="CD009695-fig-0054" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 2 Amphetamine use (hair analysis). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 3 Sustained abstinence." data-id="CD009695-fig-0055" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 3 Sustained abstinence. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 4 Self reported amphetamine use." data-id="CD009695-fig-0056" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 4 Self reported amphetamine use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-006-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-006-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 5 Retention in treatment." data-id="CD009695-fig-0057" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 5 Retention in treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-006-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-006-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 6 Amphetamine craving." data-id="CD009695-fig-0058" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 6 Amphetamine craving. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 7 Dropouts due to any adverse event." data-id="CD009695-fig-0059" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 7 Dropouts due to any adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 8 Dropouts due to cardiovascular adverse events." data-id="CD009695-fig-0060" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 8 Dropouts due to cardiovascular adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-006-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-006-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 9 Dropouts due to psychiatric adverse events." data-id="CD009695-fig-0061" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 Subgroup analysis: clinical trial reporting quality (incomplete outcome data), Outcome 9 Dropouts due to psychiatric adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-006-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Sensitivity analysis of the safety measures, Outcome 1 Dropouts due to any adverse event." data-id="CD009695-fig-0062" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Sensitivity analysis of the safety measures, Outcome 1 Dropouts due to any adverse event. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Sensitivity analysis of the safety measures, Outcome 2 Dropouts due to cardiovascular adverse events." data-id="CD009695-fig-0063" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Sensitivity analysis of the safety measures, Outcome 2 Dropouts due to cardiovascular adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Sensitivity analysis of the safety measures, Outcome 3 Dropouts due to psychiatric adverse events." data-id="CD009695-fig-0064" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Sensitivity analysis of the safety measures, Outcome 3 Dropouts due to psychiatric adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-008-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Post hoc analysis, Outcome 1 Amphetamine use (UA)." data-id="CD009695-fig-0065" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Post hoc analysis, Outcome 1 Amphetamine use (UA).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-008-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-008-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Post hoc analysis, Outcome 2 Amphetamine use (hair analysis)." data-id="CD009695-fig-0066" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Post hoc analysis, Outcome 2 Amphetamine use (hair analysis).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-008-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-008-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Post hoc analysis, Outcome 3 Sustained abstinence." data-id="CD009695-fig-0067" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Post hoc analysis, Outcome 3 Sustained abstinence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-008-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-008-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Post hoc analysis, Outcome 4 Self reported amphetamine use." data-id="CD009695-fig-0068" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Post hoc analysis, Outcome 4 Self reported amphetamine use.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-008-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-008-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Post hoc analysis, Outcome 5 Retention in treatment." data-id="CD009695-fig-0069" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Post hoc analysis, Outcome 5 Retention in treatment.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-008-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-008-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Post hoc analysis, Outcome 6 Amphetamine craving." data-id="CD009695-fig-0070" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8 Post hoc analysis, Outcome 6 Amphetamine craving.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-008-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-008-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Post hoc analysis, Outcome 7 Dropouts due to any adverse event." data-id="CD009695-fig-0071" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.7</div> <div class="figure-caption"> <p>Comparison 8 Post hoc analysis, Outcome 7 Dropouts due to any adverse event.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-008-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-008-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Post hoc analysis, Outcome 8 Dropouts due to cardiovascular adverse events." data-id="CD009695-fig-0072" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.8</div> <div class="figure-caption"> <p>Comparison 8 Post hoc analysis, Outcome 8 Dropouts due to cardiovascular adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009695-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/urn:x-wiley:14651858:media:CD009695:CD009695-CMP-008-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_t/tCD009695-CMP-008-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Post hoc analysis, Outcome 9 Dropouts due to psychiatric adverse events." data-id="CD009695-fig-0073" src="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.9</div> <div class="figure-caption"> <p>Comparison 8 Post hoc analysis, Outcome 9 Dropouts due to psychiatric adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/media/CDSR/CD009695/image_n/nCD009695-CMP-008-09.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009695-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Psychostimulants for amphetamine abuse or dependence</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Psychostimulants for amphetamine abuse or dependence</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> Amphetamine abuse or dependence<br/> <b>Settings:</b> Outpatients<br/> <b>Intervention:</b> Psychostimulants </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Psychostimulants</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Amphetamine use (UA)</b> <br/> Negative urinalyses across the study<br/> Follow‐up: 8‐12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean of the proportion of amphetamine‐negative UA ranged in the control groups from 0.56 to 33.1 </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean of the proportion of amphetamine‐negative UA ranged in the intervention groups from 0.33 to 36.85 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>473<br/> (7 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD ‐0.26</b> </p> <p>(‐0.85 to 0.33)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Sustained abstinence</b> <br/> Negative urinalyses for at least 3 consecutive weeks<br/> Follow‐up: mean 8‐12 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.12</b> <br/> (0.84 to 1.49) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>559<br/> (6 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2,3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>220 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>247 per 1000</b> <br/> (185 to 328) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>285 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>319 per 1000</b> <br/> (239 to 425) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Retention to treatment</b> <br/> Number of participants who competed treatment<br/> Follow‐up: 8‐20 weeks </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>RR 1.01</b> <br/> (0.9 to 1.14) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>791<br/> (11 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3,4,5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>489 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>494 per 1000</b> <br/> (440 to 557) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>378 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>382 per 1000</b> <br/> (340 to 431) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence:<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>The outcome is not influenced by lack of blinding, but high attrition in trials has been noted.<br/> <sup>2</sup>No statistical heterogeneity was found.<br/> <sup>3</sup>The studied intervention includes different types of psychostimulants and different doses.<br/> <sup>4</sup>95% CI is wide, and the intervention effect over this outcome can range from no benefit to small effect.<br/> <sup>5</sup>Funnel plot not suggested publication bias. Statistical power is low in using tests to detect publication bias for this comparison in this review.<br/> <sup>6</sup>This comparison includes studies with treatment length ranging from 8 to 20 weeks. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Psychostimulants for amphetamine abuse or dependence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009695-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Baseline characteristics of the participants included in the RCT of the meta‐analysis</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sample size</b> </p> <p>n</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>791</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Gender</b> </p> <p>% male</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64.9</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Age</b> </p> <p>Mean age (years)</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.9</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Race</b> </p> <p>% Caucasian</p> <p>% African‐American</p> <p>% Other</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70.5</p> <p>3.8</p> <p>25.7</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Employment status</b> </p> <p>% currently employed</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Type of dependence</b> </p> <p>% methamphetamine dependence</p> <p>% amphetamine dependence</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>92.7</p> <p>7.3</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean days of use/month</b> </p> <p>Range</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.3‐19.5</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean length of amphetamine use (years)</b> </p> <p>Range of mean lifetime amphetamine use</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7‐15.9</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Route of use</b> </p> <p>% ip</p> <p>% iv</p> <p>% in</p> <p>% oral</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.0</p> <p>22.8</p> <p>17.6</p> <p>0.6</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comorbidities</b> </p> <p>% nicotine dependent</p> <p>% ADHD</p> <p>% opioid dependent</p> <p>% alcohol dependent</p> <p>% major depression</p> <p>% psychotic disorders</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.9</p> <p>13.9</p> <p>1.6</p> <p>1,1</p> <p>0.8</p> <p>0</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>Abbreviations: ADHD = attention deficit hyperactivity disorder, ip = intrapulmonary, iv = intravenous, in = intranasal. Baseline participant characteristics are presented for those trials reporting this information. Gender, age and type of dependence were available for all studies, whereas opioid dependence and alcohol dependence from 9 studies, psychotic disorders and major depression from 8, employment status from 7, lifetime amphetamine use and ADHD from 6, race from 5 studies and nicotine dependence days of amphetamine use in a month and route of amphetamine use in 4. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Baseline characteristics of the participants included in the RCT of the meta‐analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/full#CD009695-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009695-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Psychostimulants vs placebo for amphetamine dependence</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amphetamine use (UA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>463</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐0.85, 0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Amphetamine use (hair analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [‐6.02, 7.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Sustained abstinence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.84, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Self‐reported amphetamine use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.81 [‐6.16, 4.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Retention in treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>791</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.90, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Amphetamine craving <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.44, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Dropouts due to any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.03, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Dropouts due to cardiovascular adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.03, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Dropouts due to psychiatric adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.06, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Psychostimulants vs placebo for amphetamine dependence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009695-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Subgroup analysis: type of drug</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amphetamine use (UA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Bupropion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.52 [‐4.20, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Dexamphetamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐2.66, 2.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Methylphenidate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [‐4.24, 7.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Modafinil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.84, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Amphetamine use (hair analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Dexamphetamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [‐6.02, 7.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Sustained abstinence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Bupropion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [0.87, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Modafinil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>281</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.64, 1.83]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Methylphenidate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.53, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Self‐reported amphetamine use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Methylphenidate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [‐4.76, 5.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Modafinil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.40 [‐8.44, ‐0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Dexamphetamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.71 [‐5.10, 20.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Retention in treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Bupropion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.81, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Dexamphetamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.61, 3.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Methylphenidate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.42, 1.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Modafinil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.79, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Amphetamine craving <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Bupropion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.65, 0.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Modafinil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [‐0.13, 0.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Dropouts due to any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Bupropion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.07, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Dexamphetamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.12, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Methylphenidate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.08, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 Modafinil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.04, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Dropouts due to cardiovascular adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Bupropion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.04, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Dexamphetamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.14, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Methylphenidate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.09, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4 Modafinil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.04, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Dropouts due to psychiatric adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Bupropion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.09, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Dexamphetamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.14, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 Methylphenidate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.08, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.4 Modafinil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.10, 0.05]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Subgroup analysis: type of drug</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009695-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Subgroup analysis: type of dependence</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amphetamine use (UA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Amphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [‐4.24, 7.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Methamphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.28 [‐0.87, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Amphetamine use (hair analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Amphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Methamphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [‐6.02, 7.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Sustained abstinence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Amphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.53, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Methamphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.88, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Self‐reported amphetamine use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Amphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [‐4.76, 5.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Methamphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐11.39, 11.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Retention in treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Amphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.42, 1.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Methamphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>733</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.91, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Amphetamine craving <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Amphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Methamphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.44, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Dropouts due to any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Amphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.08, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Methamphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>582</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.03, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Dropouts due to cardiovascular adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Amphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.09, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Methamphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.03, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Dropouts due to psychiatric adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Amphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.06, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Methamphetamine dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.07, 0.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Subgroup analysis: type of dependence</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009695-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Subgroup analysis: comorbid ADHD as inclusion criterion</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amphetamine use (UA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.5 [‐4.24, 7.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 No ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.28 [‐0.87, 0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Amphetamine use (hair analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 No ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [‐6.02, 7.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Sustained abstinence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.53, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 No ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.88, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Self reported amphetamine use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [‐4.76, 5.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 No ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐11.39, 11.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Retention in treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.7 [0.41, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 No ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>767</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.92, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Amphetamine craving <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 No ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.44, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Dropouts due to any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.12, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 No ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>616</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.03, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Dropouts due to cardiovascular adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.15, 0.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 No ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>346</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.03, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Dropouts due to psychiatric adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [‐0.12, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 No ADHD</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>266</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.06, 0.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Subgroup analysis: comorbid ADHD as inclusion criterion</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009695-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Subgroup analysis: data publication</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amphetamine use (UA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.22 [‐0.83, 0.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Unpublished data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>335</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.86 [‐3.21, 1.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Amphetamine use (hair analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Unpublished data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [‐6.02, 7.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Sustained abstinence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.49, 2.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Unpublished data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>486</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.83, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Self reported amphetamine use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.25 [‐7.02, 2.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Unpublished data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.71 [‐5.10, 20.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Retention in treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>791</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.90, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>791</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.90, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Unpublished data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Amphetamine craving (at the end of study) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Unpublished data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.44, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Dropouts due to any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.04, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Unpublished data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.05, 0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Dropouts due to cardiovascular adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.04, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Unpublished data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.04, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Dropouts due to psychiatric adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Published data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐0.08, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Unpublished data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.07, 0.05]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Subgroup analysis: data publication</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009695-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Subgroup analysis: clinical trial reporting quality (incomplete outcome data)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amphetamine use (UA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Low or intermediate risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.79 [‐2.55, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>359</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.82, 0.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Amphetamine use (hair analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Low or intermediate risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [‐6.02, 7.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Sustained abstinence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Low or intermediate risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>205</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.75, 1.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>354</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.70, 1.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Self reported amphetamine use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Low or intermediate risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [‐4.76, 5.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐11.39, 11.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Retention in treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Low or intermediate risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.86, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>419</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.83, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Amphetamine craving <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Low or intermediate risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.44, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Dropouts due to any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Low or intermediate risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>114</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.04, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>526</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.04, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Dropouts due to cardiovascular adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Low or intermediate risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.10, 0.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.03, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Dropouts due to psychiatric adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.06, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Low or intermediate risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐0.09, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 High risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.07, 0.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Subgroup analysis: clinical trial reporting quality (incomplete outcome data)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009695-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Sensitivity analysis of the safety measures</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Dropouts due to any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>567</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.63, 2.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Dropouts due to cardiovascular adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>193</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.30, 7.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Dropouts due to psychiatric adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.13, 2.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Sensitivity analysis of the safety measures</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009695-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Post hoc analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Amphetamine use (UA) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>473</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.26 [‐0.85, 0.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Maintenance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>444</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.62 [‐2.29, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Relapse prevention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐0.84, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Amphetamine use (hair analysis) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [‐6.02, 7.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Maintenance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.53 [‐6.02, 7.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Sustained abstinence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.84, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Maintenance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>535</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.88, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Relapse prevention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.53, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Self reported amphetamine use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.81 [‐6.16, 4.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Maintenance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.81 [‐6.16, 4.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Retention in treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>791</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.90, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Maintenance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.92, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Relapse prevention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.41, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Amphetamine craving <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.44, 0.59]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Maintenance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.44, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Dropouts due to any adverse event <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>640</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.03, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Maintenance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>607</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.03, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Relapse prevention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.11, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Dropouts due to cardiovascular adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.03, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Maintenance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>337</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.03, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Relapse prevention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.14, 0.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Dropouts due to psychiatric adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.06, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 Maintenance</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.06, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Relapse prevention</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐0.11, 0.24]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Post hoc analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009695.pub2/references#CD009695-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009695.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD009695-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009695-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009695-note-0001">Français</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009695\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009695\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009695\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009695\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009695\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xcg9958b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009695.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009695.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009695.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009695.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009695.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715356842"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009695.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715356845"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009695.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d851a08c1f446',t:'MTc0MDcxNTM1Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 